N-Q 1 filing936.htm PRIMARY DOCUMENT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY


Investment Company Act file number   811-3583


Fidelity Mt. Vernon Street Trust

(Exact name of registrant as specified in charter)


245 Summer St., Boston, Massachusetts  02210

(Address of principal executive offices)       (Zip code)


Marc Bryant, Secretary

245 Summer St.

Boston, Massachusetts  02210

(Name and address of agent for service)



Registrant's telephone number, including area code:

617-563-7000



Date of fiscal year end:

November 30



Date of reporting period:

August 31, 2017


Item 1.

Schedule of Investments




Quarterly Holdings Report
for

Fidelity® Growth Strategies K6 Fund

August 31, 2017







FEGK6-QTLY-1017
1.9883992.100





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.0%   
 Shares Value 
CONSUMER DISCRETIONARY - 15.4%   
Auto Components - 1.8%   
Tenneco, Inc. 6,653 $360,593 
Visteon Corp. (a) 7,500 865,800 
  1,226,393 
Distributors - 1.0%   
Pool Corp. 6,500 647,985 
Diversified Consumer Services - 0.8%   
Service Corp. International 14,500 512,430 
Hotels, Restaurants & Leisure - 3.8%   
Domino's Pizza, Inc. 2,719 495,565 
Jack in the Box, Inc. 4,600 430,652 
Las Vegas Sands Corp. 4,500 279,945 
Wyndham Worldwide Corp. 12,900 1,285,872 
  2,492,034 
Household Durables - 1.2%   
Newell Brands, Inc. 16,500 796,620 
Media - 2.2%   
Interpublic Group of Companies, Inc. 30,000 604,200 
Lions Gate Entertainment Corp. Class B 11,500 322,805 
Scripps Networks Interactive, Inc. Class A 2,500 214,125 
Viacom, Inc. Class B (non-vtg.) 11,500 328,900 
  1,470,030 
Multiline Retail - 1.5%   
Dollar General Corp. 5,500 399,080 
Dollar Tree, Inc. (a) 7,300 581,372 
  980,452 
Specialty Retail - 1.3%   
Ross Stores, Inc. 15,000 876,750 
Textiles, Apparel & Luxury Goods - 1.8%   
Carter's, Inc. 5,645 489,478 
Hanesbrands, Inc. 18,000 436,680 
VF Corp. 4,637 291,528 
  1,217,686 
TOTAL CONSUMER DISCRETIONARY  10,220,380 
CONSUMER STAPLES - 5.2%   
Beverages - 1.7%   
Dr. Pepper Snapple Group, Inc. 7,800 710,190 
Monster Beverage Corp. (a) 7,453 416,026 
  1,126,216 
Food Products - 1.7%   
Campbell Soup Co. 6,600 304,920 
The Hershey Co. 8,000 839,360 
  1,144,280 
Personal Products - 1.6%   
Estee Lauder Companies, Inc. Class A 5,100 545,649 
Herbalife Ltd. (a) 7,445 513,779 
  1,059,428 
Tobacco - 0.2%   
British American Tobacco PLC sponsored ADR 2,622 162,879 
TOTAL CONSUMER STAPLES  3,492,803 
ENERGY - 0.7%   
Energy Equipment & Services - 0.3%   
Baker Hughes, a GE Co. Class A 5,500 186,450 
Oil, Gas & Consumable Fuels - 0.4%   
Andeavor 2,900 290,435 
TOTAL ENERGY  476,885 
FINANCIALS - 8.6%   
Banks - 3.0%   
Citizens Financial Group, Inc. 37,000 1,225,810 
Huntington Bancshares, Inc. 42,000 528,780 
Investors Bancorp, Inc. 18,000 235,620 
  1,990,210 
Capital Markets - 2.5%   
Ameriprise Financial, Inc. 2,500 346,275 
MarketAxess Holdings, Inc. 1,000 192,950 
Moody's Corp. 4,000 536,120 
S&P Global, Inc. 3,600 555,588 
  1,630,933 
Insurance - 3.1%   
Aon PLC 2,921 406,486 
Arch Capital Group Ltd. (a) 4,500 438,030 
Progressive Corp. 26,500 1,231,720 
  2,076,236 
TOTAL FINANCIALS  5,697,379 
HEALTH CARE - 17.4%   
Health Care Equipment & Supplies - 3.2%   
Edwards Lifesciences Corp. (a) 6,700 761,522 
Intuitive Surgical, Inc. (a) 364 365,700 
ResMed, Inc. 12,595 977,120 
  2,104,342 
Health Care Providers & Services - 6.2%   
AmerisourceBergen Corp. 8,500 682,125 
Cardinal Health, Inc. 3,000 202,380 
HCA Holdings, Inc. (a) 7,000 550,620 
Henry Schein, Inc. (a) 2,900 503,672 
Laboratory Corp. of America Holdings (a) 3,200 501,984 
MEDNAX, Inc. (a) 6,000 269,100 
Universal Health Services, Inc. Class B 3,000 324,390 
Wellcare Health Plans, Inc. (a) 6,200 1,083,016 
  4,117,287 
Health Care Technology - 1.8%   
Cerner Corp. (a) 18,200 1,233,596 
Life Sciences Tools & Services - 5.5%   
Charles River Laboratories International, Inc. (a) 8,000 870,400 
Illumina, Inc. (a) 4,000 817,840 
Mettler-Toledo International, Inc. (a) 1,700 1,028,653 
Waters Corp. (a) 5,137 942,537 
  3,659,430 
Pharmaceuticals - 0.7%   
Jazz Pharmaceuticals PLC (a) 3,100 463,016 
TOTAL HEALTH CARE  11,577,671 
INDUSTRIALS - 16.0%   
Aerospace & Defense - 3.6%   
Huntington Ingalls Industries, Inc. 7,350 1,572,606 
TransDigm Group, Inc. 3,300 860,178 
  2,432,784 
Air Freight & Logistics - 0.0%   
XPO Logistics, Inc. (a) 645 39,474 
Airlines - 1.0%   
Alaska Air Group, Inc. 8,900 664,474 
Commercial Services & Supplies - 0.6%   
KAR Auction Services, Inc. 9,500 428,355 
Electrical Equipment - 0.7%   
AMETEK, Inc. 7,000 442,750 
Industrial Conglomerates - 1.9%   
Roper Technologies, Inc. 5,400 1,245,564 
Machinery - 2.8%   
Cummins, Inc. 900 143,442 
IDEX Corp. 5,500 646,690 
Toro Co. 9,000 555,120 
Wabtec Corp. 7,000 493,990 
  1,839,242 
Professional Services - 2.6%   
Dun & Bradstreet Corp. 2,800 312,032 
Equifax, Inc. 10,000 1,424,700 
  1,736,732 
Trading Companies & Distributors - 2.8%   
Fastenal Co. 19,000 810,730 
MSC Industrial Direct Co., Inc. Class A 5,500 378,840 
United Rentals, Inc. (a) 5,500 649,330 
  1,838,900 
TOTAL INDUSTRIALS  10,668,275 
INFORMATION TECHNOLOGY - 28.2%   
Communications Equipment - 1.3%   
F5 Networks, Inc. (a) 7,400 883,412 
Electronic Equipment & Components - 1.1%   
Amphenol Corp. Class A 9,066 733,802 
Internet Software & Services - 4.0%   
Akamai Technologies, Inc. (a) 13,200 622,380 
LogMeIn, Inc. 4,400 503,360 
VeriSign, Inc. (a) 15,000 1,556,250 
  2,681,990 
IT Services - 9.0%   
Amdocs Ltd. 9,800 634,942 
Fiserv, Inc. (a) 10,200 1,261,842 
FleetCor Technologies, Inc. (a) 3,900 560,703 
Genpact Ltd. 7,756 220,658 
Global Payments, Inc. 8,500 811,665 
Paychex, Inc. 14,500 826,935 
Total System Services, Inc. 24,000 1,658,880 
  5,975,625 
Semiconductors & Semiconductor Equipment - 6.7%   
Analog Devices, Inc. 13,500 1,129,545 
Broadcom Ltd. 1,300 327,691 
KLA-Tencor Corp. 12,700 1,189,863 
Lam Research Corp. 4,331 718,859 
ON Semiconductor Corp. (a) 9,500 162,260 
Skyworks Solutions, Inc. 9,000 948,240 
  4,476,458 
Software - 6.1%   
Adobe Systems, Inc. (a) 2,500 387,900 
Check Point Software Technologies Ltd. (a) 7,300 816,651 
Citrix Systems, Inc. (a) 16,000 1,251,360 
Electronic Arts, Inc. (a) 6,000 729,000 
Intuit, Inc. 1,800 254,610 
Take-Two Interactive Software, Inc. (a) 6,000 586,740 
  4,026,261 
TOTAL INFORMATION TECHNOLOGY  18,777,548 
MATERIALS - 3.5%   
Chemicals - 2.5%   
CF Industries Holdings, Inc. 11,000 318,890 
Eastman Chemical Co. 2,200 189,640 
Sherwin-Williams Co. 1,000 339,270 
The Scotts Miracle-Gro Co. Class A 4,500 430,155 
Valvoline, Inc. 18,134 386,073 
  1,664,028 
Containers & Packaging - 1.0%   
Ball Corp. 16,000 639,840 
TOTAL MATERIALS  2,303,868 
REAL ESTATE - 3.0%   
Equity Real Estate Investment Trusts (REITs) - 3.0%   
CoreSite Realty Corp. 6,400 760,064 
Digital Realty Trust, Inc. 3,500 414,190 
Equity Lifestyle Properties, Inc. 2,100 187,215 
Extra Space Storage, Inc. 8,000 621,040 
  1,982,509 
TOTAL COMMON STOCKS   
(Cost $65,206,985)  65,197,318 
Money Market Funds - 2.5%   
Fidelity Cash Central Fund, 1.11% (b)   
(Cost $1,618,220) 1,617,896 1,618,220 
TOTAL INVESTMENT IN SECURITIES - 100.5%   
(Cost $66,825,205)  66,815,538 
NET OTHER ASSETS (LIABILITIES) - (0.5)%  (302,685) 
NET ASSETS - 100%  $66,512,853 

Legend

 (a) Non-income producing

 (b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.


Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
Fidelity Cash Central Fund $1,051 
Total $1,051 

Investment Valuation

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

Other Information

During the period, an affiliated entity completed an exchange in-kind with the Fund. The affiliated entity delivered investments and cash valued at $68,107,565 in exchange for 6,736,653 shares of the Fund. The Fund recognized no gain or loss for federal income tax purposes.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Quarterly Holdings Report
for

Fidelity Flex℠ Funds

Fidelity Flex℠ Mid Cap Growth Fund

August 31, 2017







ZDG-QTLY-1017
1.9881576.100





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.3%   
 Shares Value 
CONSUMER DISCRETIONARY - 15.7%   
Auto Components - 1.9%   
Tenneco, Inc. 60 $3,252 
Visteon Corp. (a) 59 6,811 
  10,063 
Distributors - 1.0%   
Pool Corp. 51 5,084 
Diversified Consumer Services - 0.8%   
Service Corp. International 113 3,993 
Hotels, Restaurants & Leisure - 3.7%   
Domino's Pizza, Inc. 22 4,010 
Jack in the Box, Inc. 35 3,277 
Las Vegas Sands Corp. 35 2,177 
Wyndham Worldwide Corp. 100 9,968 
  19,432 
Household Durables - 1.2%   
Newell Brands, Inc. 130 6,276 
Media - 2.3%   
Interpublic Group of Companies, Inc. 262 5,277 
Lions Gate Entertainment Corp. Class B 89 2,498 
Scripps Networks Interactive, Inc. Class A 20 1,713 
Viacom, Inc. Class B (non-vtg.) 90 2,574 
  12,062 
Multiline Retail - 1.5%   
Dollar General Corp. 46 3,338 
Dollar Tree, Inc. (a) 57 4,539 
  7,877 
Specialty Retail - 1.4%   
Ross Stores, Inc. 123 7,189 
Textiles, Apparel & Luxury Goods - 1.9%   
Carter's, Inc. 45 3,902 
Hanesbrands, Inc. 143 3,469 
VF Corp. 38 2,389 
  9,760 
TOTAL CONSUMER DISCRETIONARY  81,736 
CONSUMER STAPLES - 5.0%   
Beverages - 1.6%   
Dr. Pepper Snapple Group, Inc. 59 5,372 
Monster Beverage Corp. (a) 54 3,014 
  8,386 
Food Products - 1.7%   
Campbell Soup Co. 51 2,356 
The Hershey Co. 61 6,400 
  8,756 
Personal Products - 1.5%   
Estee Lauder Companies, Inc. Class A 39 4,173 
Herbalife Ltd. (a) 50 3,451 
  7,624 
Tobacco - 0.2%   
British American Tobacco PLC sponsored ADR 19 1,180 
TOTAL CONSUMER STAPLES  25,946 
ENERGY - 0.7%   
Energy Equipment & Services - 0.3%   
Baker Hughes, a GE Co. Class A 45 1,526 
Oil, Gas & Consumable Fuels - 0.4%   
Andeavor 23 2,303 
TOTAL ENERGY  3,829 
FINANCIALS - 8.4%   
Banks - 3.0%   
Citizens Financial Group, Inc. 290 9,608 
Huntington Bancshares, Inc. 330 4,155 
Investors Bancorp, Inc. 139 1,820 
  15,583 
Capital Markets - 2.3%   
Ameriprise Financial, Inc. 19 2,632 
MarketAxess Holdings, Inc. 1,351 
Moody's Corp. 31 4,155 
S&P Global, Inc. 25 3,858 
  11,996 
Insurance - 3.1%   
Aon PLC 22 3,062 
Arch Capital Group Ltd. (a) 37 3,602 
Progressive Corp. 207 9,621 
  16,285 
TOTAL FINANCIALS  43,864 
HEALTH CARE - 17.5%   
Health Care Equipment & Supplies - 3.1%   
Edwards Lifesciences Corp. (a) 53 6,024 
Intuitive Surgical, Inc. (a) 3,014 
ResMed, Inc. 94 7,293 
  16,331 
Health Care Providers & Services - 6.2%   
AmerisourceBergen Corp. 66 5,297 
Cardinal Health, Inc. 22 1,484 
HCA Holdings, Inc. (a) 53 4,169 
Henry Schein, Inc. (a) 23 3,995 
Laboratory Corp. of America Holdings (a) 25 3,922 
MEDNAX, Inc. (a) 50 2,243 
Universal Health Services, Inc. Class B 24 2,595 
Wellcare Health Plans, Inc. (a) 48 8,385 
  32,090 
Health Care Technology - 1.9%   
Cerner Corp. (a) 142 9,625 
Life Sciences Tools & Services - 5.6%   
Charles River Laboratories International, Inc. (a) 62 6,746 
Illumina, Inc. (a) 33 6,747 
Mettler-Toledo International, Inc. (a) 14 8,471 
Waters Corp. (a) 39 7,156 
  29,120 
Pharmaceuticals - 0.7%   
Jazz Pharmaceuticals PLC (a) 24 3,585 
TOTAL HEALTH CARE  90,751 
INDUSTRIALS - 16.8%   
Aerospace & Defense - 3.7%   
Huntington Ingalls Industries, Inc. 57 12,196 
TransDigm Group, Inc. 27 7,038 
  19,234 
Air Freight & Logistics - 0.5%   
XPO Logistics, Inc. (a) 45 2,754 
Airlines - 1.1%   
Alaska Air Group, Inc. 75 5,600 
Commercial Services & Supplies - 0.6%   
KAR Auction Services, Inc. 73 3,292 
Electrical Equipment - 0.7%   
AMETEK, Inc. 54 3,416 
Industrial Conglomerates - 1.9%   
Roper Technologies, Inc. 42 9,688 
Machinery - 2.9%   
Cummins, Inc. 10 1,594 
IDEX Corp. 43 5,056 
Toro Co. 70 4,318 
Wabtec Corp. 55 3,881 
  14,849 
Professional Services - 2.7%   
Dun & Bradstreet Corp. 27 3,009 
Equifax, Inc. 78 11,113 
  14,122 
Trading Companies & Distributors - 2.7%   
Fastenal Co. 145 6,187 
MSC Industrial Direct Co., Inc. Class A 41 2,824 
United Rentals, Inc. (a) 45 5,313 
  14,324 
TOTAL INDUSTRIALS  87,279 
INFORMATION TECHNOLOGY - 27.8%   
Communications Equipment - 1.3%   
F5 Networks, Inc. (a) 58 6,924 
Electronic Equipment & Components - 1.1%   
Amphenol Corp. Class A 69 5,585 
Internet Software & Services - 4.2%   
Akamai Technologies, Inc. (a) 115 5,422 
LogMeIn, Inc. 34 3,890 
VeriSign, Inc. (a) 119 12,346 
  21,658 
IT Services - 8.7%   
Amdocs Ltd. 76 4,924 
Fiserv, Inc. (a) 76 9,402 
FleetCor Technologies, Inc. (a) 29 4,169 
Genpact Ltd. 57 1,622 
Global Payments, Inc. 65 6,207 
Paychex, Inc. 111 6,330 
Total System Services, Inc. 183 12,642 
  45,296 
Semiconductors & Semiconductor Equipment - 6.7%   
Analog Devices, Inc. 100 8,367 
Broadcom Ltd. 10 2,521 
KLA-Tencor Corp. 100 9,369 
Lam Research Corp. 35 5,809 
ON Semiconductor Corp. (a) 80 1,366 
Skyworks Solutions, Inc. 69 7,270 
  34,702 
Software - 5.8%   
Adobe Systems, Inc. (a) 19 2,948 
Check Point Software Technologies Ltd. (a) 55 6,153 
Citrix Systems, Inc. (a) 126 9,854 
Electronic Arts, Inc. (a) 40 4,860 
Intuit, Inc. 14 1,980 
Take-Two Interactive Software, Inc. (a) 45 4,401 
  30,196 
TOTAL INFORMATION TECHNOLOGY  144,361 
MATERIALS - 3.4%   
Chemicals - 2.5%   
CF Industries Holdings, Inc. 90 2,609 
Eastman Chemical Co. 18 1,552 
Sherwin-Williams Co. 2,375 
The Scotts Miracle-Gro Co. Class A 35 3,346 
Valvoline, Inc. 136 2,895 
  12,777 
Containers & Packaging - 0.9%   
Ball Corp. 121 4,839 
TOTAL MATERIALS  17,616 
REAL ESTATE - 3.0%   
Equity Real Estate Investment Trusts (REITs) - 3.0%   
CoreSite Realty Corp. 50 5,938 
Digital Realty Trust, Inc. 26 3,077 
Equity Lifestyle Properties, Inc. 16 1,426 
Extra Space Storage, Inc. 63 4,891 
  15,332 
TOTAL COMMON STOCKS   
(Cost $490,620)  510,714 
Money Market Funds - 0.9%   
Fidelity Cash Central Fund, 1.11% (b)   
(Cost $4,674) 4,673 4,674 
TOTAL INVESTMENT IN SECURITIES - 99.2%   
(Cost $495,294)  515,388 
NET OTHER ASSETS (LIABILITIES) - 0.8%  4,385 
NET ASSETS - 100%  $519,773 

Legend

 (a) Non-income producing

 (b) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.


Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
Fidelity Cash Central Fund $77 
Total $77 

Investment Valuation

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Quarterly Holdings Report
for

Fidelity® Growth Company Fund

August 31, 2017







GCF-QTLY-1017
1.805820.113





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 97.3%   
 Shares Value (000s) 
CONSUMER DISCRETIONARY - 20.7%   
Auto Components - 0.0%   
Delphi Automotive PLC 46,600 $4,492 
Automobiles - 1.7%   
Tesla, Inc. (a)(b) 1,967,000 700,055 
Hotels, Restaurants & Leisure - 2.3%   
China Lodging Group Ltd. ADR (a) 391,500 44,439 
Chipotle Mexican Grill, Inc. (a)(b) 70,900 22,455 
Dave & Buster's Entertainment, Inc. (a) 170,422 9,963 
Del Taco Restaurants, Inc. (a) 975,400 13,734 
Domino's Pizza, Inc. 149,986 27,336 
Dunkin' Brands Group, Inc. 243,740 12,567 
Hyatt Hotels Corp. Class A (a) 160,840 9,572 
Las Vegas Sands Corp. 830,600 51,672 
Marriott International, Inc. Class A 153,400 15,889 
McDonald's Corp. 1,429,500 228,677 
Papa John's International, Inc. 741,400 55,449 
Shake Shack, Inc. Class A (a)(b) 667,700 20,645 
Starbucks Corp. 4,041,800 221,733 
U.S. Foods Holding Corp. (a) 523,700 14,376 
Wingstop, Inc. (b) 45,300 1,468 
Yum China Holdings, Inc. 2,004,100 70,865 
Yum! Brands, Inc. 1,121,500 86,154 
  906,994 
Household Durables - 0.0%   
Newell Brands, Inc. 207,654 10,026 
Sony Corp. sponsored ADR 132,600 5,255 
  15,281 
Internet & Direct Marketing Retail - 8.0%   
Amazon.com, Inc. (a) 1,836,601 1,800,971 
Blue Apron Holdings, Inc.:   
Class A (b) 1,428,400 7,485 
Class B 1,769,256 8,344 
Class B 442,313 2,202 
Ctrip.com International Ltd. ADR (a) 1,431,200 73,635 
Etsy, Inc. (a) 197,300 3,230 
Expedia, Inc. 716,600 106,315 
Groupon, Inc. (a) 9,086,100 40,342 
JD.com, Inc. sponsored ADR (a) 5,724,300 239,905 
Netflix, Inc. (a) 2,127,400 371,678 
Priceline Group, Inc. (a) 118,268 219,042 
The Honest Co., Inc. (a)(c)(d) 39,835 996 
TripAdvisor, Inc. (a)(b) 112,600 4,811 
Vipshop Holdings Ltd. ADR (a) 9,579,200 89,182 
Wayfair LLC Class A (a)(b) 3,284,067 233,202 
  3,201,340 
Leisure Products - 0.1%   
Callaway Golf Co. 2,032,300 28,330 
Media - 1.4%   
Comcast Corp. Class A 9,492,800 385,503 
Liberty Media Corp. Liberty Formula One Group Series C (a) 542,500 21,320 
Lions Gate Entertainment Corp.:   
Class A (b) 102,946 3,061 
Class B 102,946 2,890 
The Walt Disney Co. 1,629,800 164,936 
Turn, Inc. (Escrow) (c)(d) 984,774 709 
  578,419 
Multiline Retail - 0.2%   
Dollar General Corp. 182,500 13,242 
Dollar Tree, Inc. (a) 889,200 70,816 
Target Corp. 46,389 2,530 
  86,588 
Specialty Retail - 1.1%   
CarMax, Inc. (a) 149,521 10,040 
DavidsTea, Inc. (a)(b) 312,500 1,672 
Home Depot, Inc. 2,103,200 315,207 
L Brands, Inc. 143,000 5,179 
Lowe's Companies, Inc. 362,400 26,778 
RH (a)(b)(e) 1,215,803 56,887 
TJX Companies, Inc. 345,800 25,001 
  440,764 
Textiles, Apparel & Luxury Goods - 5.9%   
adidas AG 5,279,338 1,184,997 
Kering SA 499,500 187,487 
lululemon athletica, Inc. (a)(e) 8,114,378 466,982 
LVMH Moet Hennessy - Louis Vuitton SA 178,522 46,892 
NIKE, Inc. Class B 2,800,300 147,884 
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) 9,031,285 238,697 
Tory Burch LLC:   
Class A(a)(c)(d)(f) 950,844 42,094 
Class B (a)(c)(d)(f) 324,840 15,261 
Under Armour, Inc. Class C (non-vtg.) (a)(b) 453,104 6,842 
VF Corp. 428,400 26,934 
  2,364,070 
TOTAL CONSUMER DISCRETIONARY  8,326,333 
CONSUMER STAPLES - 5.1%   
Beverages - 2.1%   
Constellation Brands, Inc. Class A (sub. vtg.) 323,100 64,652 
Dr. Pepper Snapple Group, Inc. 175,700 15,997 
Monster Beverage Corp. (a) 7,268,618 405,734 
PepsiCo, Inc. 1,007,340 116,579 
The Coca-Cola Co. 5,627,300 256,324 
  859,286 
Food & Staples Retailing - 0.6%   
Costco Wholesale Corp. 937,400 146,928 
Drogasil SA 2,739,373 60,351 
Kroger Co. 217,050 4,747 
Walgreens Boots Alliance, Inc. 600,300 48,924 
  260,950 
Food Products - 0.4%   
Campbell Soup Co. 125,100 5,780 
General Mills, Inc. 147,400 7,851 
Kellogg Co. 106,500 6,971 
Lamb Weston Holdings, Inc. 539,700 24,546 
Mondelez International, Inc. 610,600 24,827 
The Hain Celestial Group, Inc. (a) 302,600 12,171 
The Hershey Co. 266,000 27,909 
The Kraft Heinz Co. 460,500 37,185 
  147,240 
Household Products - 0.3%   
Church & Dwight Co., Inc. 827,500 41,516 
Colgate-Palmolive Co. 431,800 30,934 
Kimberly-Clark Corp. 246,700 30,416 
Procter & Gamble Co. 93,700 8,646 
  111,512 
Personal Products - 0.8%   
Coty, Inc. Class A 8,031,300 133,159 
elf Beauty, Inc. (b) 177,500 3,672 
Herbalife Ltd. (a)(b) 1,560,910 107,718 
Unilever NV (Certificaten Van Aandelen) (Bearer) 1,092,500 65,041 
  309,590 
Tobacco - 0.9%   
Altria Group, Inc. 2,852,280 180,835 
British American Tobacco PLC sponsored ADR 764,700 47,503 
Philip Morris International, Inc. 1,137,380 132,994 
  361,332 
TOTAL CONSUMER STAPLES  2,049,910 
ENERGY - 1.2%   
Energy Equipment & Services - 0.2%   
Baker Hughes, a GE Co. Class A 1,357,400 46,016 
Halliburton Co. 372,300 14,509 
U.S. Silica Holdings, Inc. 610,000 16,598 
  77,123 
Oil, Gas & Consumable Fuels - 1.0%   
Anadarko Petroleum Corp. 264,000 10,806 
Cabot Oil & Gas Corp. 1,260,900 32,216 
Concho Resources, Inc. (a) 432,900 48,039 
Continental Resources, Inc. (a) 479,000 16,248 
Diamondback Energy, Inc. (a) 300,933 27,322 
EOG Resources, Inc. 1,324,600 112,578 
Hess Corp. 93,900 3,653 
Noble Energy, Inc. 1,065,611 25,330 
PDC Energy, Inc. (a) 476,000 18,721 
Pioneer Natural Resources Co. 378,107 49,022 
Reliance Industries Ltd. 1,246,912 31,097 
Valero Energy Corp. 218,400 14,873 
  389,905 
TOTAL ENERGY  467,028 
FINANCIALS - 2.4%   
Banks - 1.0%   
Bank of America Corp. 1,100,600 26,293 
Citigroup, Inc. 517,780 35,225 
HDFC Bank Ltd. sponsored ADR 1,386,674 135,104 
JPMorgan Chase & Co. 1,750,900 159,139 
Signature Bank (a) 57,285 7,352 
Wells Fargo & Co. 794,700 40,585 
  403,698 
Capital Markets - 1.3%   
BlackRock, Inc. Class A 454,600 190,482 
BM&F BOVESPA SA 5,687,997 39,970 
Charles Schwab Corp. 6,942,975 277,025 
E*TRADE Financial Corp. (a) 316,500 12,980 
RPI International Holdings LP (a)(c)(d) 130,847 17,717 
T. Rowe Price Group, Inc. 60,400 5,095 
  543,269 
Consumer Finance - 0.1%   
American Express Co. 229,048 19,721 
Discover Financial Services 126,544 7,460 
  27,181 
TOTAL FINANCIALS  974,148 
HEALTH CARE - 17.8%   
Biotechnology - 13.9%   
AbbVie, Inc. 1,510,491 113,740 
ACADIA Pharmaceuticals, Inc. (a)(e) 2,929,105 104,305 
ACADIA Pharmaceuticals, Inc. (a)(b)(e) 4,414,403 157,197 
Adverum Biotechnologies, Inc. (a) 452,900 1,245 
Agios Pharmaceuticals, Inc. (a)(b) 1,987,189 125,710 
Alexion Pharmaceuticals, Inc. (a) 1,497,260 213,225 
Alkermes PLC (a)(e) 9,395,726 477,115 
Alnylam Pharmaceuticals, Inc. (a)(e) 4,778,836 409,690 
Amgen, Inc. 1,366,500 242,923 
Array BioPharma, Inc. (a) 5,820,670 56,344 
aTyr Pharma, Inc. (a)(b)(e) 335,669 1,024 
aTyr Pharma, Inc. (a)(e)(g) 1,469,144 4,481 
BeiGene Ltd. ADR (a)(b) 1,869,476 128,844 
Biogen, Inc. (a) 349,900 110,764 
Bioverativ, Inc. 137,950 7,820 
bluebird bio, Inc. (a)(e) 2,568,889 320,726 
Calyxt, Inc. (e) 1,540,700 23,419 
Celgene Corp. (a) 1,119,688 155,558 
Celldex Therapeutics, Inc. (a) 2,010,393 4,946 
Cellectis SA sponsored ADR (a) 706,911 20,331 
Chimerix, Inc. (a)(e) 2,401,057 11,429 
Coherus BioSciences, Inc. (a)(b) 2,317,362 33,486 
CytomX Therapeutics, Inc. (a) 628,013 10,852 
CytomX Therapeutics, Inc. (a)(g) 794,033 13,721 
Dicerna Pharmaceuticals, Inc. (a) 181,250 633 
Editas Medicine, Inc. (a)(b) 826,582 17,449 
Exelixis, Inc. (a)(e) 15,761,767 460,874 
Fate Therapeutics, Inc. (a)(b) 1,489,106 5,629 
Five Prime Therapeutics, Inc. (a) 1,316,033 44,640 
Galapagos Genomics NV sponsored ADR (a) 885,714 81,920 
Genocea Biosciences, Inc. (a)(b) 119,400 581 
Gilead Sciences, Inc. 1,897,895 158,873 
Global Blood Therapeutics, Inc. (a) 1,035,875 31,491 
Heron Therapeutics, Inc. (a)(b) 1,650,375 27,231 
Intellia Therapeutics, Inc. (a)(b) 904,500 19,022 
Intercept Pharmaceuticals, Inc. (a)(b) 187,354 21,847 
Intrexon Corp. (a)(b) 493,975 9,746 
Ionis Pharmaceuticals, Inc. (a)(b)(e) 7,630,214 409,132 
Ironwood Pharmaceuticals, Inc. Class A (a) 5,401,693 86,157 
Jounce Therapeutics, Inc. (b) 485,300 8,245 
Lexicon Pharmaceuticals, Inc. (a)(b)(e) 6,964,138 105,437 
Macrogenics, Inc. (a) 259,100 4,900 
Merrimack Pharmaceuticals, Inc. (b) 5,267,621 7,164 
Momenta Pharmaceuticals, Inc. (a)(e) 5,164,458 87,021 
Opko Health, Inc. (a)(b) 84,398 540 
Protagonist Therapeutics, Inc. 442,439 7,225 
Prothena Corp. PLC (a)(e) 2,156,533 132,497 
Regeneron Pharmaceuticals, Inc. (a) 1,022,818 508,238 
Regulus Therapeutics, Inc. (a)(b)(e) 5,400,499 5,400 
Rigel Pharmaceuticals, Inc. (a)(e) 9,345,837 23,832 
Sage Therapeutics, Inc. (a)(e) 1,931,373 158,855 
Seattle Genetics, Inc. (a) 2,118,536 111,287 
Seres Therapeutics, Inc. (a) 1,188,442 16,674 
Seres Therapeutics, Inc. (a)(g) 572,827 8,037 
Sienna Biopharmaceuticals, Inc. 763,858 19,112 
Sienna Biopharmaceuticals, Inc. 564,045 12,701 
Spark Therapeutics, Inc. (a) 414,000 34,085 
Syros Pharmaceuticals, Inc. (a)(b)(e) 725,902 14,206 
Syros Pharmaceuticals, Inc. (e)(g) 938,007 18,357 
TESARO, Inc. (a)(b) 430,365 55,577 
Ultragenyx Pharmaceutical, Inc. (a) 750,900 42,846 
Versartis, Inc. (a) 515,094 9,787 
Vertex Pharmaceuticals, Inc. (a) 301,067 48,333 
Xencor, Inc. (a) 817,332 17,671 
  5,582,147 
Health Care Equipment & Supplies - 1.5%   
Abbott Laboratories 634,929 32,343 
Align Technology, Inc. (a) 135,356 23,923 
Danaher Corp. 1,340,000 111,783 
DexCom, Inc. (a) 471,700 35,194 
Genmark Diagnostics, Inc. (a) 1,528,853 14,891 
Insulet Corp. (a) 1,976,100 114,732 
Intuitive Surgical, Inc. (a) 130,793 131,404 
Novocure Ltd. (a)(b) 1,398,900 28,677 
Novocure Ltd. (a)(g) 571,461 11,715 
Penumbra, Inc. (a) 1,207,587 103,852 
Presbia PLC (a)(e) 1,349,493 4,035 
  612,549 
Health Care Providers & Services - 0.5%   
Apollo Hospitals Enterprise Ltd. 720,000 12,192 
Humana, Inc. 41,600 10,717 
McKesson Corp. 99,900 14,916 
UnitedHealth Group, Inc. 804,100 159,935 
  197,760 
Health Care Technology - 0.3%   
athenahealth, Inc. (a) 673,300 94,888 
Castlight Health, Inc. Class B (a)(b) 2,263,694 8,828 
Cerner Corp. (a) 123,700 8,384 
  112,100 
Life Sciences Tools & Services - 0.0%   
Illumina, Inc. (a) 54,538 11,151 
Pharmaceuticals - 1.6%   
Adimab LLC (a)(c)(d)(f) 3,162,765 108,356 
Akcea Therapeutics, Inc. 2,517,995 46,961 
Avexis, Inc. (a) 1,580,442 147,534 
Bristol-Myers Squibb Co. 1,751,400 105,925 
Castle Creek Pharmaceuticals, LLC Class A-2 unit (c)(d)(f)(h) 46,864 19,375 
Endocyte, Inc. (a)(b) 1,137,115 1,546 
Intra-Cellular Therapies, Inc. (a)(b)(e) 3,098,711 57,171 
Jazz Pharmaceuticals PLC (a) 404,800 60,461 
Kolltan Pharmaceuticals, Inc. rights (d) 7,940,644 953 
Stemcentrx, Inc. rights 12/31/21 (d) 2,065,715 6,073 
The Medicines Company (a)(b) 2,427,600 89,069 
Theravance Biopharma, Inc. (a)(b) 816,253 26,667 
  670,091 
TOTAL HEALTH CARE  7,185,798 
INDUSTRIALS - 5.8%   
Aerospace & Defense - 1.0%   
Lockheed Martin Corp. 497,300 151,870 
Northrop Grumman Corp. 66,621 18,135 
Space Exploration Technologies Corp. Class A (a)(c)(d) 418,210 56,458 
The Boeing Co. 564,700 135,336 
United Technologies Corp. 456,600 54,664 
  416,463 
Air Freight & Logistics - 0.3%   
FedEx Corp. 93,300 20,002 
United Parcel Service, Inc. Class B 1,002,800 114,680 
  134,682 
Airlines - 1.7%   
Allegiant Travel Co. 133,200 15,718 
Azul SA sponsored ADR (b) 563,400 14,091 
Delta Air Lines, Inc. 963,300 45,458 
InterGlobe Aviation Ltd. 637,747 12,252 
JetBlue Airways Corp. (a) 7,985,123 158,185 
Ryanair Holdings PLC sponsored ADR (a) 493,852 56,151 
Southwest Airlines Co. 2,581,415 134,595 
United Continental Holdings, Inc. (a) 1,656,300 102,624 
Wheels Up Partners Holdings LLC:   
Series B (a)(c)(d)(f) 6,703,518 20,915 
Series C(a)(c)(d)(f) 3,466,281 10,815 
Wizz Air Holdings PLC (a) 3,019,548 114,990 
  685,794 
Electrical Equipment - 0.3%   
AMETEK, Inc. 67,800 4,288 
Eaton Corp. PLC 454,000 32,579 
Emerson Electric Co. 408,400 24,112 
Fortive Corp. 680,600 44,219 
  105,198 
Industrial Conglomerates - 0.9%   
3M Co. 946,900 193,471 
Honeywell International, Inc. 1,125,600 155,637 
  349,108 
Machinery - 1.2%   
Aumann AG 213,600 16,594 
Caterpillar, Inc. 2,292,500 269,346 
Cummins, Inc. 266,900 42,539 
Deere & Co. 417,400 48,389 
Illinois Tool Works, Inc. 317,500 43,659 
Rational AG 4,182 2,716 
Wabtec Corp. (b) 212,700 15,010 
Xylem, Inc. 1,065,300 66,123 
  504,376 
Road & Rail - 0.3%   
Union Pacific Corp. 1,190,000 125,307 
Trading Companies & Distributors - 0.1%   
Univar, Inc. (a) 1,037,400 29,265 
TOTAL INDUSTRIALS  2,350,193 
INFORMATION TECHNOLOGY - 42.1%   
Communications Equipment - 0.3%   
Arista Networks, Inc. (a) 80,800 14,233 
Infinera Corp. (a)(b)(e) 11,256,128 95,227 
Palo Alto Networks, Inc. (a) 74,500 9,885 
  119,345 
Electronic Equipment & Components - 0.2%   
Cognex Corp. 27,300 2,975 
IPG Photonics Corp. (a) 22,000 3,867 
TE Connectivity Ltd. 111,700 8,891 
Trimble, Inc. (a) 1,509,100 58,372 
  74,105 
Internet Software & Services - 11.9%   
2U, Inc. (a) 221,727 11,109 
Actua Corp. (a)(e) 2,347,321 30,046 
Alibaba Group Holding Ltd. sponsored ADR (a) 1,305,900 224,275 
Alphabet, Inc.:   
Class A (a) 1,504,578 1,437,233 
Class C (a) 820,983 771,174 
Apptio, Inc. Class A 1,279,266 22,771 
Baidu.com, Inc. sponsored ADR (a) 119,471 27,245 
Cloudera, Inc. 529,285 9,755 
Criteo SA sponsored ADR (a)(b) 413,040 20,119 
Dropbox, Inc. Class B (a)(c)(d) 1,105,082 14,167 
eBay, Inc. (a) 561,800 20,298 
Facebook, Inc. Class A (a) 8,070,591 1,387,900 
GoDaddy, Inc. (a) 401,100 17,977 
NAVER Corp. 8,760 5,883 
NetEase, Inc. ADR 635,300 175,241 
New Relic, Inc. (a) 465,179 22,282 
Nutanix, Inc.:   
Class A 2,857,600 62,867 
Class B (g) 1,151,309 25,329 
Okta, Inc. (b) 91,400 2,467 
Shopify, Inc. Class A (a) 3,550,996 392,422 
Tencent Holdings Ltd. 1,178,900 49,608 
Twitter, Inc. (a) 37,790 639 
Wix.com Ltd. (a) 969,700 63,127 
  4,793,934 
IT Services - 3.3%   
Black Knight Financial Services, Inc. Class A(a)(b) 90,400 3,851 
Cognizant Technology Solutions Corp. Class A 1,035,632 73,292 
IBM Corp. 248,700 35,572 
MasterCard, Inc. Class A 2,531,900 337,502 
PayPal Holdings, Inc. (a) 5,410,300 333,707 
Square, Inc. (a) 3,061,800 79,944 
Visa, Inc. Class A 4,504,105 466,265 
  1,330,133 
Semiconductors & Semiconductor Equipment - 10.4%   
Advanced Micro Devices, Inc. (a)(b) 9,328,300 121,268 
Applied Materials, Inc. 363,600 16,406 
ASML Holding NV 420,793 65,774 
Broadcom Ltd. 617,602 155,679 
Cavium, Inc. (a) 2,309,860 146,237 
Cirrus Logic, Inc. (a) 1,741,867 100,993 
Cree, Inc. (a) 1,111,171 27,035 
Cypress Semiconductor Corp. 631,700 8,648 
Inphi Corp. (a)(b) 353,500 13,536 
Intel Corp. 80,500 2,823 
KLA-Tencor Corp. 258,400 24,209 
M/A-COM Technology Solutions Holdings, Inc. (a) 491,001 22,360 
Micron Technology, Inc. (a) 939,600 30,039 
NVIDIA Corp. 17,411,751 2,950,241 
Qorvo, Inc. (a) 241,200 17,661 
Silicon Laboratories, Inc. (a)(e) 3,342,552 253,700 
Skyworks Solutions, Inc. 127,131 13,395 
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR 1,300,800 48,091 
Texas Instruments, Inc. 1,847,300 152,993 
  4,171,088 
Software - 10.1%   
Activision Blizzard, Inc. 8,772,408 575,119 
Adobe Systems, Inc. (a) 1,853,036 287,517 
Appirio, Inc. (Escrow) (c)(d) 389,363 96 
Atlassian Corp. PLC (a) 473,200 16,846 
Autodesk, Inc. (a) 899,900 103,003 
Electronic Arts, Inc. (a) 1,970,552 239,422 
HubSpot, Inc. (a) 1,749,700 128,340 
Intuit, Inc. 485,700 68,702 
Microsoft Corp. 11,479,117 858,294 
Oracle Corp. 1,063,200 53,511 
Paylocity Holding Corp. (a) 180,900 8,889 
Proofpoint, Inc. (a) 380,400 34,906 
Red Hat, Inc. (a) 3,889,086 418,077 
Salesforce.com, Inc. (a) 12,365,312 1,180,764 
Snap, Inc. Class A (a)(b) 4,234,254 61,439 
Zendesk, Inc. (a) 1,779,600 48,761 
  4,083,686 
Technology Hardware, Storage & Peripherals - 5.9%   
Apple, Inc. 13,889,748 2,277,919 
NetApp, Inc. 424,100 16,396 
Pure Storage, Inc. Class A (a) 3,481,619 51,841 
Samsung Electronics Co. Ltd. 16,437 33,861 
Western Digital Corp. 97,013 8,563 
  2,388,580 
TOTAL INFORMATION TECHNOLOGY  16,960,871 
MATERIALS - 1.3%   
Chemicals - 1.3%   
CF Industries Holdings, Inc. 1,099,125 31,864 
E.I. du Pont de Nemours & Co. 1,393,900 116,990 
LyondellBasell Industries NV Class A 134,200 12,157 
Monsanto Co. 835,971 97,976 
Praxair, Inc. 191,000 25,124 
The Dow Chemical Co. 1,816,600 121,076 
The Mosaic Co. 256,400 5,123 
The Scotts Miracle-Gro Co. Class A 1,349,861 129,033 
  539,343 
Containers & Packaging - 0.0%   
Aptargroup, Inc. 54,900 4,590 
TOTAL MATERIALS  543,933 
REAL ESTATE - 0.3%   
Equity Real Estate Investment Trusts (REITs) - 0.3%   
American Tower Corp. 677,700 100,333 
Real Estate Management & Development - 0.0%   
Redfin Corp. (b) 71,700 1,598 
TOTAL REAL ESTATE  101,931 
TELECOMMUNICATION SERVICES - 0.6%   
Diversified Telecommunication Services - 0.1%   
Verizon Communications, Inc. 1,020,900 48,973 
Wireless Telecommunication Services - 0.5%   
T-Mobile U.S., Inc. (a) 2,788,900 180,470 
TOTAL TELECOMMUNICATION SERVICES  229,443 
TOTAL COMMON STOCKS   
(Cost $18,790,459)  39,189,588 
Preferred Stocks - 2.4%   
Convertible Preferred Stocks - 2.3%   
CONSUMER DISCRETIONARY - 0.2%   
Hotels, Restaurants & Leisure - 0.0%   
MOD Super Fast Pizza Holdings LLC Series 3 Preferred (c)(d)(f) 56,343 6,722 
Household Durables - 0.1%   
Roku, Inc.:   
Series F, 8.00% (a)(c)(d) 17,901,305 33,475 
Series G, 8.00% (a)(c)(d) 2,750,007 5,143 
Series H (a)(c)(d) 823,979 1,541 
  40,159 
Internet & Direct Marketing Retail - 0.0%   
The Honest Co., Inc.:   
Series C (a)(c)(d) 92,950 2,810 
Series D (a)(c)(d) 69,363 2,220 
  5,030 
Leisure Products - 0.0%   
Peloton Interactive, Inc. Series E (c)(d) 637,482 13,809 
Textiles, Apparel & Luxury Goods - 0.1%   
Homology Medicines, Inc. Series B (c)(d) 3,750,001 5,400 
Rubius Therapeutics, Inc. Series B (c)(d) 1,287,247 13,284 
  18,684 
TOTAL CONSUMER DISCRETIONARY  84,404 
FINANCIALS - 0.1%   
Diversified Financial Services - 0.1%   
Neon Therapeutics, Inc. Series B (c)(d) 3,188,856 11,352 
UNITY Biotechnology, Inc. Series B (c)(d) 2,214,616 10,032 
  21,384 
Insurance - 0.0%   
Clover Health Series D (c)(d) 863,631 8,099 
TOTAL FINANCIALS  29,483 
HEALTH CARE - 0.9%   
Biotechnology - 0.8%   
10X Genomics, Inc. Series C (a)(c)(d) 2,505,940 11,222 
23andMe, Inc. Series F (c) 590,383 8,197 
Axcella Health, Inc. Series C (a)(c)(d) 536,592 5,409 
Immunocore Ltd. Series A (a)(c)(d) 67,323 22,828 
Intarcia Therapeutics, Inc.:   
Series CC (a)(c)(d) 1,051,411 63,085 
Series DD (a)(c)(d) 1,543,687 92,621 
Moderna Therapeutics, Inc.:   
Series B (c)(d) 242,837 1,751 
Series C (c)(d) 554,903 4,001 
Series D (c)(d) 4,688,230 33,802 
Series E (c)(d) 5,651,170 40,745 
Series F (c)(d) 140,212 1,011 
Translate Bio:   
Series B (a)(c)(d) 4,408,601 12,653 
Series C (c)(d) 1,959,621 5,624 
  302,949 
Health Care Providers & Services - 0.1%   
Mulberry Health, Inc. Series A8 (a)(c)(d) 2,790,742 17,741 
Health Care Technology - 0.0%   
Codiak Biosciences, Inc.:   
Series A (a)(c)(d) 589,863 1,947 
Series B (a)(c)(d) 1,917,058 6,326 
  8,273 
Pharmaceuticals - 0.0%   
OptiNose U.S., Inc. Series D (c)(d) 343,700 13,748 
TOTAL HEALTH CARE  342,711 
INDUSTRIALS - 0.2%   
Aerospace & Defense - 0.1%   
Space Exploration Technologies Corp. Series G (a)(c)(d) 216,276 29,197 
Commercial Services & Supplies - 0.0%   
Domo, Inc. Series D (a)(c)(d) 2,990,903 22,668 
Professional Services - 0.1%   
YourPeople, Inc. Series C (c)(d) 5,833,137 48,765 
TOTAL INDUSTRIALS  100,630 
INFORMATION TECHNOLOGY - 0.9%   
Internet Software & Services - 0.6%   
Jet.Com, Inc. Series B1 (Escrow) (a)(c)(d) 7,578,338 2,489 
Reddit, Inc. Series B (c)(d) 384,303 6,062 
Starry, Inc. Series B (c)(d) 9,869,159 5,339 
Uber Technologies, Inc.:   
Series D, 8.00% (a)(c)(d) 4,770,180 232,652 
Series E, 8.00% (a)(c)(d) 209,216 10,204 
  256,746 
IT Services - 0.1%   
AppNexus, Inc. Series E (a)(c)(d) 923,523 21,038 
Software - 0.2%   
Appirio, Inc. Series E (Escrow) (c)(d) 2,725,544 693 
Cloudflare, Inc. Series D 8.00% (a)(c)(d) 1,429,726 9,379 
Dataminr, Inc. Series D (a)(c)(d) 1,773,901 15,323 
MongoDB, Inc. Series F, 8.00% (a)(c)(d) 1,913,404 35,196 
Outset Medical, Inc. Series C (c)(d) 1,244,716 3,226 
Taboola.Com Ltd. Series E (a)(c)(d) 1,337,420 17,956 
  81,773 
TOTAL INFORMATION TECHNOLOGY  359,557 
TELECOMMUNICATION SERVICES - 0.0%   
Wireless Telecommunication Services - 0.0%   
Altiostar Networks, Inc. Series A1 (c)(d) 699,106 3,216 
TOTAL CONVERTIBLE PREFERRED STOCKS  920,001 
Nonconvertible Preferred Stocks - 0.1%   
FINANCIALS - 0.1%   
Banks - 0.1%   
Itau Unibanco Holding SA 1,874,400 24,027 
HEALTH CARE - 0.0%   
Biotechnology - 0.0%   
Yumanity Holdings LLC Class A (a)(c)(d) 464,607 5,194 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  29,221 
TOTAL PREFERRED STOCKS   
(Cost $627,449)  949,222 
Money Market Funds - 1.4%   
Fidelity Cash Central Fund, 1.11% (i) 120,643,932 120,668 
Fidelity Securities Lending Cash Central Fund 1.11% (i)(j) 423,373,099 423,415 
TOTAL MONEY MARKET FUNDS   
(Cost $544,050)  544,083 
TOTAL INVESTMENT IN SECURITIES - 101.1%   
(Cost $19,961,958)  40,682,893 
NET OTHER ASSETS (LIABILITIES) - (1.1)%  (424,255) 
NET ASSETS - 100%  $40,258,638 

Values shown as $0 may reflect amounts less than $500.

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $1,190,060,000 or 3.0% of net assets.

 (d) Level 3 instrument

 (e) Affiliated company

 (f) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (g) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $81,640,000 or 0.2% of net assets.

 (h) Investment represents common shares and preferred shares.

 (i) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (j) Investment made with cash collateral received from securities on loan.


Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost (000s) 
10X Genomics, Inc. Series C 2/23/16 - 4/3/17 $11,222 
23andMe, Inc. Series F 8/31/17 $8,197 
Adimab LLC 9/17/14 - 6/5/15 $47,869 
Altiostar Networks, Inc. Series A1 1/10/17 $3,216 
Appirio, Inc. (Escrow) 7/7/17 $90 
Appirio, Inc. Series E (Escrow) 11/24/16 $693 
AppNexus, Inc. Series E 8/1/14 $18,500 
Axcella Health, Inc. Series C 8/11/17 $5,409 
Castle Creek Pharmaceuticals, LLC Class A-2 unit 9/29/16 $15,465 
Cloudflare, Inc. Series D 8.00% 11/5/14 $8,758 
Clover Health Series D 6/7/17 $8,099 
Codiak Biosciences, Inc. Series A 11/12/15 $590 
Codiak Biosciences, Inc. Series B 11/12/15 $5,751 
Dataminr, Inc. Series D 2/18/15 - 3/6/15 $22,617 
Domo, Inc. Series D 1/24/14 $12,362 
Dropbox, Inc. Class B 5/2/12 $10,000 
Homology Medicines, Inc. Series B 7/28/17 $5,400 
Immunocore Ltd. Series A 7/27/15 $12,669 
Intarcia Therapeutics, Inc. Series CC 11/14/12 $14,331 
Intarcia Therapeutics, Inc. Series DD 3/17/14 $50,000 
Jet.Com, Inc. Series B1 (Escrow) 9/19/16 $2,489 
MOD Super Fast Pizza Holdings LLC Series 3 Preferred 11/3/16 $7,719 
Moderna Therapeutics, Inc. Series B 4/13/17 $1,408 
Moderna Therapeutics, Inc. Series C 4/13/17 $3,224 
Moderna Therapeutics, Inc. Series D 11/6/13 $20,615 
Moderna Therapeutics, Inc. Series E 12/18/14 $24,850 
Moderna Therapeutics, Inc. Series F 8/10/16 $617 
MongoDB, Inc. Series F, 8.00% 10/2/13 $32,000 
Mulberry Health, Inc. Series A8 1/20/16 $18,851 
Neon Therapeutics, Inc. Series B 12/28/16 $8,961 
OptiNose U.S., Inc. Series D 3/24/17 $11,291 
Outset Medical, Inc. Series C 4/19/17 $3,226 
Peloton Interactive, Inc. Series E 3/31/17 $13,809 
Reddit, Inc. Series B 7/26/17 $5,456 
Roku, Inc. Series F, 8.00% 5/7/13 - 5/28/13 $16,212 
Roku, Inc. Series G, 8.00% 10/1/14 $3,574 
Roku, Inc. Series H 11/9/15 $1,260 
RPI International Holdings LP 5/21/15 - 3/23/16 $16,269 
Rubius Therapeutics, Inc. Series B 6/7/17 $10,800 
Space Exploration Technologies Corp. Class A 10/16/15 - 4/6/17 $38,201 
Space Exploration Technologies Corp. Series G 1/20/15 $16,753 
Starry, Inc. Series B 12/1/16 $5,339 
Taboola.Com Ltd. Series E 12/22/14 $13,943 
The Honest Co., Inc. 8/21/14 $1,078 
The Honest Co., Inc. Series C 8/21/14 $2,515 
The Honest Co., Inc. Series D 8/3/15 $3,174 
Tory Burch LLC Class A 5/14/15 $67,653 
Tory Burch LLC Class B 12/31/12 $17,505 
Translate Bio Series B 7/17/15 $4,761 
Translate Bio Series C 12/22/16 $3,880 
Turn, Inc. (Escrow) 4/11/17 $709 
Uber Technologies, Inc. Series D, 8.00% 6/6/14 $74,000 
Uber Technologies, Inc. Series E, 8.00% 12/5/14 $6,971 
UNITY Biotechnology, Inc. Series B 10/14/16 $9,102 
Wheels Up Partners Holdings LLC Series B 9/18/15 $19,040 
Wheels Up Partners Holdings LLC Series C 6/22/17 $10,815 
YourPeople, Inc. Series C 5/1/15 $86,920 
Yumanity Holdings LLC Class A 2/8/16 $3,140 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
 (Amounts in thousands) 
Fidelity Cash Central Fund $438 
Fidelity Securities Lending Cash Central Fund 7,045 
Total $7,483 

Other Affiliated Issuers

An affiliated company is a company in which the Fund has ownership of at least 5% of the voting securities. Fiscal year to date transactions with companies which are or were affiliates are as follows:

Affiliate (Amounts in thousands) Value, beginning of period Purchases Sales Proceeds* Dividend Income Realized Gain (loss) Change in Unrealized appreciation (depreciation) Value, end of period 
ACADIA Pharmaceuticals, Inc. $79,057 $-- $-- $-- $-- $25,248 $104,305 
ACADIA Pharmaceuticals, Inc. 108,950 29,330 15,053 -- 8,698 25,272 157,197 
Actua Corp. 43,200 -- 11,740 -- (2,243) 829 30,046 
Alkermes PLC 564,496 32,544 63,178 -- 47,638 (104,385) 477,115 
Alnylam Pharmaceuticals, Inc. 211,633 34,474 24,375 -- 7,788 180,170 409,690 
Applied Micro Circuits Corp. 53,082 -- 51,460 -- (489) (1,133) -- 
Apptio, Inc. 15,712 -- -- -- -- 4,288 -- 
Apptio, Inc. Class A 8,213 1,307 1,604 -- (323) (4,822) -- 
aTyr Pharma, Inc. 1,743 17 658 -- (3,620) 3,542 1,024 
aTyr Pharma, Inc. 4,554 -- -- -- (73) -- 4,481 
bluebird bio, Inc. 146,921 38,434 21,706 -- 15,297 141,780 320,726 
Calyxt, Inc. -- 12,774 -- -- -- 10,645 23,419 
Chimerix, Inc. 14,256 96 2,873 -- (8,880) 8,830 11,429 
Exelixis, Inc. 308,449 3,203 51,017 -- 30,877 169,362 460,874 
HubSpot, Inc. 100,001 11,321 10,809 -- 2,531 25,296 -- 
Infinera Corp. 106,776 863 13,420 -- (4,577) 5,585 95,227 
Intra-Cellular Therapies, Inc. 47,622 1,034 5,739 -- 3,314 10,940 57,171 
Ionis Pharmaceuticals, Inc. 354,387 23,488 42,486 -- 27,142 46,601 409,132 
Lexicon Pharmaceuticals, Inc. 103,734 14,628 11,299 -- 5,043 (6,669) 105,437 
lululemon athletica, Inc. 512,051 9,417 63,515 -- 46,742 (37,712) 466,983 
Merrimack Pharmaceuticals, Inc. 41,377 -- 5,127 6,931 (14,121) (14,965) -- 
Momenta Pharmaceuticals, Inc. 76,442 6,166 9,465 -- 863 13,015 87,021 
Nutanix, Inc. Class A 30,867 40,100 7,195 -- (1,669) 764 -- 
Nutanix, Inc. Class B 33,158 -- -- -- -- (7,829) -- 
NVIDIA Corp. 2,768,858 25,835 1,552,680 8,705 1,336,130 390,502 -- 
Presbia PLC 5,184 937 468 -- (172) (1,446) 4,035 
Prothena Corp. PLC 126,623 14,745 12,997 -- 10,134 (6,008) 132,497 
Regulus Therapeutics, Inc. 7,632 2,423 654 -- (2,255) (1,746) 5,400 
RH 77,545 1,186 44,076 -- (32,319) 54,551 56,887 
Rigel Pharmaceuticals, Inc. 21,349 4,531 2,783 -- 545 190 23,832 
Sage Therapeutics, Inc. 100,093 12,968 13,030 -- 10,052 48,772 158,855 
Silicon Laboratories, Inc. 215,457 34,249 25,271 -- 8,186 21,079 253,700 
Syros Pharmaceuticals, Inc. 11,084 12 1,195 -- 64 4,241 14,206 
Syros Pharmaceuticals, Inc. 12,101 -- -- -- -- 6,256 18,357 
Wizz Air Holdings PLC 64,452 9,512 7,465 -- 744 47,747 -- 
Total $6,377,059 $365,594 $2,073,338 $15,636 $1,491,047 $1,058,790 $ 3,889,046 

 * Includes the value of securities delivered through in-kind transactions, if applicable.


Investment Valuation

The following is a summary of the inputs used, as of August 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.

 Valuation Inputs at Reporting Date: 
Description Total Level 1 Level 2 Level 3 
(Amounts in thousands)     
Investments in Securities:     
Equities:     
Consumer Discretionary $8,410,737 $8,209,835 $57,438 $143,464 
Consumer Staples 2,049,910 1,984,869 65,041 -- 
Energy 467,028 467,028 -- -- 
Financials 1,027,658 980,458 -- 47,200 
Health Care 7,533,703 7,038,340 12,701 482,662 
Industrials 2,450,823 2,262,005 -- 188,818 
Information Technology 17,320,428 16,887,245 59,363 373,820 
Materials 543,933 543,933 -- -- 
Real Estate 101,931 101,931 -- -- 
Telecommunication Services 232,659 229,443 -- 3,216 
Money Market Funds 544,083 544,083 -- -- 
Total Investments in Securities: $40,682,893 $39,249,170 $194,543 $1,239,180 

The following is a summary of transfers between Level 1 and Level 2 for the period ended August 31, 2017. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:

Transfers Total (000s) 
Level 1 to Level 2 $0 
Level 2 to Level 1 $797,730 

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:

(Amounts in thousands)  
Investments in Securities:  
Equities - Health Care  
Beginning Balance $402,671 
Net Realized Gain (Loss) on Investment Securities -- 
Net Unrealized Gain (Loss) on Investment Securities 44,689 
Cost of Purchases 35,302 
Proceeds of Sales -- 
Amortization/Accretion -- 
Transfers into Level 3 -- 
Transfers out of Level 3 -- 
Ending Balance $482,662 
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at August 31, 2017 $44,689 
Equities - Information Technology  
Beginning Balance $415,705 
Net Realized Gain (Loss) on Investment Securities -- 
Net Unrealized Gain (Loss) on Investment Securities 12,829 
Cost of Purchases 14,119 
Proceeds of Sales (68,833) 
Amortization/Accretion -- 
Transfers into Level 3 -- 
Transfers out of Level 3 -- 
Ending Balance $373,820 
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at August 31, 2017 $21,024 
Other Investments in Securities  
Beginning Balance $321,219 
Net Realized Gain (Loss) on Investment Securities (43,260) 
Net Unrealized Gain (Loss) on Investment Securities 55,546 
Cost of Purchases 68,247 
Proceeds of Sales (19,054) 
Amortization/Accretion -- 
Transfers into Level 3 -- 
Transfers out of Level 3 -- 
Ending Balance $382,698 
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at August 31, 2017 $12,347 

The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

The following provides information on Level 3 securities held by the fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.

Asset Type Fair Value Valuation Technique (s) Unobservable Input Amount or Range / Weighted Average Impact to Valuation from an Increase in Input(a) 
Equities $1,239,180 Recovery value Recovery value 0.2% - 0.7% / 0.4% Increase 
  Market approach Transaction price $0.54 - $135.00 / $57.62 Increase 
  Market comparable Enterprise value/EBITDA multiple (EV/EBITDA) 6.9 Increase 
   Enterprise value/Sales multiple (EV/S) 0.7 - 14.3 / 5.4 Increase 
   Transaction price $1.44 - $330.00 / $55.16 Increase 
   Discount rate 8.0% - 69.0% / 28.8% Decrease 
   Discount for lack of marketability 10.0% - 20.0% / 14.9% Decrease 
   Liquidity preference $6.75 - $70.93 / $42.94 Increase 
   Premium rate 15.0% - 144.0% / 67.6% Increase 
   Proxy premium 10.0% - 76.0% / 29.5% Increase 
  Discount cash flow Discount rate 8.0% - 12.2% / 10.8% Decrease 
   Discount for lack of marketability 10.0% Decrease 
   Probability rate 6.3% - 69.0% / 6.8% Increase 

 (a) Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.


For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Quarterly Holdings Report
for

Fidelity® Growth Strategies Fund

August 31, 2017







FEG-QTLY-1017
1.805759.113





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 98.2%   
 Shares Value (000s) 
CONSUMER DISCRETIONARY - 15.5%   
Auto Components - 1.9%   
Tenneco, Inc. 289,400 15,685 
Visteon Corp. (a) 287,246 33,160 
  48,845 
Distributors - 1.0%   
Pool Corp. 252,738 25,195 
Diversified Consumer Services - 0.8%   
Service Corp. International 548,162 19,372 
Hotels, Restaurants & Leisure - 3.7%   
Domino's Pizza, Inc. 104,690 19,081 
Jack in the Box, Inc. 184,778 17,299 
Las Vegas Sands Corp. 183,900 11,440 
Wyndham Worldwide Corp. 487,060 48,550 
  96,370 
Household Durables - 1.2%   
Newell Brands, Inc. 640,100 30,904 
Media - 2.3%   
Interpublic Group of Companies, Inc. 1,217,800 24,526 
Lions Gate Entertainment Corp. Class B 455,996 12,800 
Scripps Networks Interactive, Inc. Class A 89,653 7,679 
Viacom, Inc. Class B (non-vtg.) 528,200 15,107 
  60,112 
Multiline Retail - 1.5%   
Dollar General Corp. 220,000 15,963 
Dollar Tree, Inc. (a) 284,034 22,620 
  38,583 
Specialty Retail - 1.3%   
Ross Stores, Inc. 575,000 33,609 
Textiles, Apparel & Luxury Goods - 1.8%   
Carter's, Inc. 216,561 18,778 
Hanesbrands, Inc. (b) 716,000 17,370 
VF Corp. 175,450 11,031 
  47,179 
TOTAL CONSUMER DISCRETIONARY  400,169 
CONSUMER STAPLES - 5.2%   
Beverages - 1.7%   
Dr. Pepper Snapple Group, Inc. 302,200 27,515 
Monster Beverage Corp. (a) 277,600 15,496 
  43,011 
Food Products - 1.7%   
Campbell Soup Co. 261,100 12,063 
The Hershey Co. 310,900 32,620 
  44,683 
Personal Products - 1.6%   
Estee Lauder Companies, Inc. Class A 200,000 21,398 
Herbalife Ltd. (a)(b) 277,684 19,163 
  40,561 
Tobacco - 0.2%   
British American Tobacco PLC sponsored ADR 99,652 6,190 
TOTAL CONSUMER STAPLES  134,445 
ENERGY - 0.7%   
Energy Equipment & Services - 0.3%   
Baker Hughes, a GE Co. Class A 231,709 7,855 
Oil, Gas & Consumable Fuels - 0.4%   
Andeavor 103,800 10,396 
TOTAL ENERGY  18,251 
FINANCIALS - 8.7%   
Banks - 3.0%   
Citizens Financial Group, Inc. 1,461,119 48,407 
Huntington Bancshares, Inc. 1,652,320 20,803 
Investors Bancorp, Inc. 701,400 9,181 
  78,391 
Capital Markets - 2.5%   
Ameriprise Financial, Inc. 96,989 13,434 
MarketAxess Holdings, Inc. 41,000 7,911 
Moody's Corp. 153,010 20,508 
S&P Global, Inc. 137,700 21,251 
  63,104 
Insurance - 3.2%   
Aon PLC 110,600 15,391 
Arch Capital Group Ltd. (a) 187,000 18,203 
Progressive Corp. 1,023,308 47,563 
  81,157 
TOTAL FINANCIALS  222,652 
HEALTH CARE - 17.3%   
Health Care Equipment & Supplies - 3.1%   
Edwards Lifesciences Corp. (a) 258,200 29,347 
Intuitive Surgical, Inc. (a) 14,000 14,065 
ResMed, Inc. 473,500 36,734 
  80,146 
Health Care Providers & Services - 6.2%   
AmerisourceBergen Corp. 328,100 26,330 
Cardinal Health, Inc. 108,649 7,329 
HCA Holdings, Inc. (a) 272,099 21,403 
Henry Schein, Inc. (a) 116,566 20,245 
Laboratory Corp. of America Holdings (a) 126,100 19,781 
MEDNAX, Inc. (a) 230,000 10,316 
Universal Health Services, Inc. Class B 122,700 13,268 
Wellcare Health Plans, Inc. (a) 236,900 41,382 
  160,054 
Health Care Technology - 1.9%   
Cerner Corp. (a) 702,384 47,608 
Life Sciences Tools & Services - 5.4%   
Charles River Laboratories International, Inc. (a) 308,700 33,587 
Illumina, Inc. (a) 140,476 28,722 
Mettler-Toledo International, Inc. (a) 67,700 40,965 
Waters Corp. (a) 192,600 35,338 
  138,612 
Pharmaceuticals - 0.7%   
Jazz Pharmaceuticals PLC (a) 124,766 18,635 
TOTAL HEALTH CARE  445,055 
INDUSTRIALS - 16.2%   
Aerospace & Defense - 3.7%   
Huntington Ingalls Industries, Inc. 281,468 60,223 
TransDigm Group, Inc. (b) 130,000 33,886 
  94,109 
Air Freight & Logistics - 0.0%   
XPO Logistics, Inc. (a) 21,500 1,316 
Airlines - 1.0%   
Alaska Air Group, Inc. 344,864 25,748 
Commercial Services & Supplies - 0.7%   
KAR Auction Services, Inc. 375,100 16,913 
Electrical Equipment - 0.7%   
Acuity Brands, Inc. (b) 7,407 1,309 
AMETEK, Inc. 274,172 17,341 
  18,650 
Industrial Conglomerates - 1.9%   
Roper Technologies, Inc. 209,500 48,323 
Machinery - 2.8%   
Cummins, Inc. 34,914 5,565 
IDEX Corp. 219,200 25,774 
Toro Co. 345,917 21,336 
Wabtec Corp. (b) 269,349 19,008 
  71,683 
Professional Services - 2.6%   
Dun & Bradstreet Corp. 108,100 12,047 
Equifax, Inc. 394,378 56,187 
  68,234 
Trading Companies & Distributors - 2.8%   
Fastenal Co. 730,000 31,149 
MSC Industrial Direct Co., Inc. Class A 233,885 16,110 
United Rentals, Inc. (a) 210,000 24,793 
  72,052 
TOTAL INDUSTRIALS  417,028 
INFORMATION TECHNOLOGY - 28.3%   
Communications Equipment - 1.3%   
F5 Networks, Inc. (a) 287,500 34,322 
Electronic Equipment & Components - 1.1%   
Amphenol Corp. Class A 341,000 27,601 
Internet Software & Services - 4.1%   
Akamai Technologies, Inc. (a) 509,600 24,028 
LogMeIn, Inc. 173,307 19,826 
VeriSign, Inc. (a)(b) 586,100 60,808 
  104,662 
IT Services - 8.8%   
Amdocs Ltd. 360,899 23,383 
Fiserv, Inc. (a) 373,151 46,163 
FleetCor Technologies, Inc. (a) 148,200 21,307 
Genpact Ltd. 292,428 8,320 
Global Payments, Inc. 331,200 31,626 
Paychex, Inc. 578,348 32,983 
Total System Services, Inc. 916,470 63,344 
  227,126 
Semiconductors & Semiconductor Equipment - 6.9%   
Analog Devices, Inc. 507,838 42,491 
Broadcom Ltd. 58,900 14,847 
KLA-Tencor Corp. 494,000 46,283 
Lam Research Corp. 181,700 30,159 
ON Semiconductor Corp. (a) 433,446 7,403 
Skyworks Solutions, Inc. 345,033 36,353 
  177,536 
Software - 6.1%   
Adobe Systems, Inc. (a) 96,400 14,957 
Check Point Software Technologies Ltd. (a) 286,108 32,007 
Citrix Systems, Inc. (a) 644,000 50,367 
Electronic Arts, Inc. (a) 232,950 28,303 
Intuit, Inc. 67,500 9,548 
Take-Two Interactive Software, Inc. (a) 222,387 21,747 
  156,929 
TOTAL INFORMATION TECHNOLOGY  728,176 
MATERIALS - 3.3%   
Chemicals - 2.5%   
CF Industries Holdings, Inc. 459,100 13,309 
Eastman Chemical Co. 91,355 7,875 
Sherwin-Williams Co. 39,700 13,469 
The Scotts Miracle-Gro Co. Class A 165,941 15,862 
Valvoline, Inc. 680,000 14,477 
  64,992 
Containers & Packaging - 0.8%   
Ball Corp. 509,804 20,387 
TOTAL MATERIALS  85,379 
REAL ESTATE - 3.0%   
Equity Real Estate Investment Trusts (REITs) - 3.0%   
CoreSite Realty Corp. 247,000 29,334 
Digital Realty Trust, Inc. 134,500 15,917 
Equity Lifestyle Properties, Inc. 83,257 7,422 
Extra Space Storage, Inc. 324,400 25,183 
  77,856 
TOTAL COMMON STOCKS   
(Cost $2,324,172)  2,529,011 
Money Market Funds - 5.9%   
Fidelity Cash Central Fund, 1.11% (c) 40,433,316 40,441 
Fidelity Securities Lending Cash Central Fund 1.11% (c)(d) 111,223,437 111,235 
TOTAL MONEY MARKET FUNDS   
(Cost $151,686)  151,676 
TOTAL INVESTMENT IN SECURITIES - 104.1%   
(Cost $2,475,858)  2,680,687 
NET OTHER ASSETS (LIABILITIES) - (4.1)%  (105,788) 
NET ASSETS - 100%  $2,574,899 

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (d) Investment made with cash collateral received from securities on loan.


Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
 (Amounts in thousands) 
Fidelity Cash Central Fund $242 
Fidelity Securities Lending Cash Central Fund 645 
Total $887 

Investment Valuation

All investments are categorized as Level 1 under the Fair Value Hierarchy. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs is provided later in this section.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Quarterly Holdings Report
for

Fidelity® New Millennium Fund®

August 31, 2017







NMF-QTLY-1017
1.805750.113





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 94.0%   
 Shares Value (000s) 
CONSUMER DISCRETIONARY - 12.5%   
Auto Components - 0.4%   
Magna International, Inc. Class A (sub. vtg.) (a) 280,900 $13,517 
Automobiles - 1.3%   
Fiat Chrysler Automobiles NV (b) 1,933,300 29,251 
Tesla, Inc. (b) 29,900 10,641 
  39,892 
Distributors - 0.4%   
Pool Corp. 119,500 11,913 
Hotels, Restaurants & Leisure - 3.2%   
ARAMARK Holdings Corp. 1,571,300 63,936 
Noodles & Co. (a)(b) 1,142,458 4,398 
U.S. Foods Holding Corp. (b) 732,600 20,110 
Whitbread PLC 227,498 11,055 
  99,499 
Household Durables - 1.8%   
D.R. Horton, Inc. 550,700 19,908 
NVR, Inc. (b) 6,900 18,774 
Toll Brothers, Inc. 474,813 18,499 
  57,181 
Internet & Direct Marketing Retail - 0.9%   
Priceline Group, Inc. (b) 16,000 29,633 
Leisure Products - 0.0%   
New Academy Holding Co. LLC unit (b)(c)(d)(e) 66,000 1,328 
Media - 0.3%   
WME Entertainment Parent, LLC Class A (b)(d)(e)(f) 3,633,768 9,084 
Multiline Retail - 0.7%   
Dollar General Corp. 207,500 15,056 
Macy's, Inc. 331,500 6,885 
  21,941 
Specialty Retail - 2.3%   
AutoZone, Inc. (b) 31,700 16,752 
Citi Trends, Inc. 340,716 6,177 
Tiffany & Co., Inc. 330,000 30,162 
TJX Companies, Inc. 265,000 19,160 
  72,251 
Textiles, Apparel & Luxury Goods - 1.2%   
Brunello Cucinelli SpA 822,600 24,677 
Hermes International SCA 22,100 11,689 
  36,366 
TOTAL CONSUMER DISCRETIONARY  392,605 
CONSUMER STAPLES - 6.1%   
Beverages - 0.8%   
Molson Coors Brewing Co. Class B 278,000 24,951 
Food & Staples Retailing - 3.8%   
Costco Wholesale Corp. 155,900 24,436 
CVS Health Corp. 260,000 20,108 
Kroger Co. 1,120,500 24,505 
Wal-Mart Stores, Inc. 646,600 50,480 
  119,529 
Food Products - 1.1%   
Amira Nature Foods Ltd. (a)(b) 1,082,352 5,769 
Amplify Snack Brands, Inc. (a)(b) 1,271,118 9,165 
Associated British Foods PLC 311,700 13,390 
Greencore Group PLC 2,384,461 6,321 
  34,645 
Personal Products - 0.4%   
Coty, Inc. Class A 669,500 11,100 
TOTAL CONSUMER STAPLES  190,225 
ENERGY - 11.4%   
Energy Equipment & Services - 1.6%   
Borr Drilling Ltd. 3,068,503 11,549 
Oceaneering International, Inc. 585,052 13,193 
Odfjell Drilling A/S (b) 5,127,100 15,729 
TechnipFMC PLC 325,600 8,410 
  48,881 
Oil, Gas & Consumable Fuels - 9.8%   
Anadarko Petroleum Corp. 540,400 22,119 
Cabot Oil & Gas Corp. 711,100 18,169 
Chevron Corp. 517,000 55,640 
Cimarex Energy Co. 126,300 12,591 
ConocoPhillips Co. 990,400 43,241 
Denbury Resources, Inc. (a)(b) 2,486,300 2,635 
Diamondback Energy, Inc. (b) 215,500 19,565 
Energy Transfer Equity LP 416,500 7,235 
GasLog Ltd. (a) 377,541 6,343 
Golar LNG Ltd. (a) 552,600 11,980 
Legacy Reserves LP (b) 2,372,300 2,918 
Southwestern Energy Co. (b) 510,600 2,783 
The Williams Companies, Inc. 2,251,900 66,949 
Whiting Petroleum Corp. (b) 479,700 2,144 
Williams Partners LP 843,900 33,250 
  307,562 
TOTAL ENERGY  356,443 
FINANCIALS - 18.1%   
Banks - 7.3%   
Bank of America Corp. 4,140,500 98,914 
First Republic Bank 206,200 20,012 
Metro Bank PLC (a)(b) 243,010 10,901 
PNC Financial Services Group, Inc. 288,600 36,193 
Republic First Bancorp, Inc. (a)(b) 933,900 7,891 
SunTrust Banks, Inc. 424,112 23,369 
U.S. Bancorp 621,000 31,826 
  229,106 
Capital Markets - 2.0%   
Brighthouse Financial, Inc. 28,045 1,601 
KKR & Co. LP 1,235,604 23,489 
Morgan Stanley 813,300 37,005 
  62,095 
Insurance - 6.6%   
AIA Group Ltd. 2,385,200 18,303 
American International Group, Inc. 705,000 42,638 
Arch Capital Group Ltd. (b) 308,200 30,000 
Chubb Ltd. 309,709 43,799 
First American Financial Corp. 559,800 27,464 
FNF Group 657,300 31,708 
MetLife, Inc. 308,500 14,447 
  208,359 
Mortgage Real Estate Investment Trusts - 0.1%   
KKR Real Estate Finance Trust, Inc. 172,700 3,587 
Thrifts & Mortgage Finance - 2.1%   
Housing Development Finance Corp. Ltd. 425,968 11,839 
MGIC Investment Corp. (b) 1,967,300 22,526 
Radian Group, Inc. 1,774,923 31,061 
  65,426 
TOTAL FINANCIALS  568,573 
HEALTH CARE - 11.7%   
Health Care Equipment & Supplies - 2.6%   
Boston Scientific Corp. (b) 1,857,500 51,174 
DexCom, Inc. (b) 120,000 8,953 
Intuitive Surgical, Inc. (b) 9,600 9,645 
Sartorius Stedim Biotech 102,900 7,540 
Teleflex, Inc. 15,501 3,282 
  80,594 
Health Care Providers & Services - 3.4%   
Amplifon SpA 1,041,550 15,065 
Premier, Inc. (b) 239,400 8,020 
Teladoc, Inc. (a)(b) 191,300 6,418 
UnitedHealth Group, Inc. 301,900 60,048 
Universal Health Services, Inc. Class B 154,000 16,652 
  106,203 
Health Care Technology - 1.1%   
Cerner Corp. (b) 231,200 15,671 
HealthStream, Inc. (b) 279,010 6,554 
Medidata Solutions, Inc. (b) 165,500 12,406 
  34,631 
Life Sciences Tools & Services - 3.1%   
Agilent Technologies, Inc. 377,200 24,412 
Eurofins Scientific SA 128,400 73,385 
  97,797 
Pharmaceuticals - 1.5%   
Catalent, Inc. (b) 248,493 10,260 
GlaxoSmithKline PLC 1,184,600 23,502 
Prestige Brands Holdings, Inc. (b) 300,000 15,213 
  48,975 
TOTAL HEALTH CARE  368,200 
INDUSTRIALS - 10.5%   
Aerospace & Defense - 4.1%   
General Dynamics Corp. 239,300 48,183 
KEYW Holding Corp. (a)(b) 1,870,437 13,374 
Northrop Grumman Corp. 142,700 38,844 
Space Exploration Technologies Corp. Class A (b)(d)(e) 52,593 7,100 
Teledyne Technologies, Inc. (b) 75,700 11,360 
TransDigm Group, Inc. 35,700 9,306 
  128,167 
Air Freight & Logistics - 1.8%   
C.H. Robinson Worldwide, Inc. (a) 244,600 17,276 
Expeditors International of Washington, Inc. 170,000 9,537 
FedEx Corp. 107,000 22,939 
Hub Group, Inc. Class A (b) 207,916 7,994 
  57,746 
Commercial Services & Supplies - 1.0%   
KAR Auction Services, Inc. 283,900 12,801 
Stericycle, Inc. (b) 125,800 9,044 
U.S. Ecology, Inc. 193,056 9,923 
  31,768 
Electrical Equipment - 0.4%   
Melrose Industries PLC 4,653,496 13,238 
Machinery - 1.5%   
Aumann AG 223,600 17,371 
Flowserve Corp. 158,200 6,214 
Pentair PLC 160,200 9,940 
Rational AG 21,300 13,832 
  47,357 
Marine - 0.3%   
Goodbulk Ltd. (e) 447,903 5,485 
Hapag-Lloyd AG (b) 47,594 2,058 
  7,543 
Road & Rail - 0.4%   
Genesee & Wyoming, Inc. Class A (b) 164,900 11,306 
Trading Companies & Distributors - 1.0%   
Rush Enterprises, Inc. Class A (b) 241,500 9,899 
United Rentals, Inc. (b) 187,000 22,077 
  31,976 
TOTAL INDUSTRIALS  329,101 
INFORMATION TECHNOLOGY - 15.2%   
Communications Equipment - 2.2%   
Cisco Systems, Inc. 1,773,300 57,118 
Juniper Networks, Inc. 392,700 10,890 
  68,008 
Electronic Equipment & Components - 2.1%   
Amphenol Corp. Class A 280,182 22,678 
CDW Corp. 182,000 11,542 
IPG Photonics Corp. (b) 114,000 20,040 
Keysight Technologies, Inc. (b) 290,000 11,849 
  66,109 
Internet Software & Services - 3.1%   
Akamai Technologies, Inc. (b) 505,300 23,825 
Alphabet, Inc.:   
Class A (b) 11,000 10,508 
Class C (b) 10,400 9,769 
Endurance International Group Holdings, Inc. (b) 1,110,200 8,549 
Facebook, Inc. Class A (b) 124,200 21,359 
GoDaddy, Inc. (b) 380,400 17,050 
LogMeIn, Inc. 72,423 8,285 
  99,345 
IT Services - 4.6%   
First Data Corp. (b)(g) 1,067,762 19,657 
First Data Corp. Class A (b) 1,372,000 25,259 
FleetCor Technologies, Inc. (b) 53,900 7,749 
Leidos Holdings, Inc. 340,800 19,875 
PayPal Holdings, Inc. (b) 557,200 34,368 
Visa, Inc. Class A 356,100 36,863 
  143,771 
Semiconductors & Semiconductor Equipment - 1.1%   
KLA-Tencor Corp. 86,700 8,123 
Maxim Integrated Products, Inc. 140,200 6,542 
Qualcomm, Inc. 374,900 19,596 
  34,261 
Software - 2.1%   
ANSYS, Inc. (b) 131,500 16,940 
Aspen Technology, Inc. (b) 531,000 33,586 
Citrix Systems, Inc. (b) 207,300 16,213 
Trion World, Inc. (b)(d)(e) 1,062,359 
Trion World, Inc. warrants 10/3/18 (b)(d)(e) 42,310 
  66,739 
TOTAL INFORMATION TECHNOLOGY  478,233 
MATERIALS - 1.8%   
Chemicals - 0.3%   
Potash Corp. of Saskatchewan, Inc. 514,800 8,958 
Construction Materials - 0.1%   
Forterra, Inc. (a) 407,800 1,354 
Metals & Mining - 1.4%   
Franco-Nevada Corp. 143,800 11,764 
Freeport-McMoRan, Inc. (b) 838,200 12,389 
Newcrest Mining Ltd. 541,982 9,845 
Novagold Resources, Inc. (a)(b) 2,591,580 11,269 
  45,267 
TOTAL MATERIALS  55,579 
REAL ESTATE - 1.2%   
Equity Real Estate Investment Trusts (REITs) - 0.8%   
Cousins Properties, Inc. 901,553 8,430 
Healthcare Trust of America, Inc. 274,800 8,538 
Parkway, Inc. 112,694 2,587 
VEREIT, Inc. 471,400 3,979 
  23,534 
Real Estate Management & Development - 0.4%   
Realogy Holdings Corp. 414,300 14,045 
TOTAL REAL ESTATE  37,579 
TELECOMMUNICATION SERVICES - 1.2%   
Diversified Telecommunication Services - 1.2%   
Verizon Communications, Inc. 794,000 38,088 
UTILITIES - 4.3%   
Electric Utilities - 4.3%   
Alliant Energy Corp. 409,800 17,515 
Duke Energy Corp. 295,300 25,780 
Exelon Corp. 454,100 17,197 
IDACORP, Inc. 260,800 23,206 
OGE Energy Corp. 265,200 9,473 
Southern Co. 320,100 15,448 
Xcel Energy, Inc. 557,200 27,581 
  136,200 
TOTAL COMMON STOCKS   
(Cost $2,404,684)  2,950,826 
Preferred Stocks - 0.7%   
Convertible Preferred Stocks - 0.2%   
CONSUMER DISCRETIONARY - 0.2%   
Leisure Products - 0.2%   
Peloton Interactive, Inc. Series E (d)(e) 230,821 5,000 
INDUSTRIALS - 0.0%   
Aerospace & Defense - 0.0%   
Space Exploration Technologies Corp. Series H (d)(e) 7,570 1,022 
TOTAL CONVERTIBLE PREFERRED STOCKS  6,022 
Nonconvertible Preferred Stocks - 0.5%   
CONSUMER DISCRETIONARY - 0.4%   
Automobiles - 0.4%   
Porsche Automobil Holding SE (Germany) 222,673 12,621 
HEALTH CARE - 0.1%   
Health Care Equipment & Supplies - 0.1%   
Sartorius AG (non-vtg.) 39,029 3,877 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  16,498 
TOTAL PREFERRED STOCKS   
(Cost $21,778)  22,520 
 Principal Amount (000s) Value (000s) 
Corporate Bonds - 0.2%   
Convertible Bonds - 0.0%   
INFORMATION TECHNOLOGY - 0.0%   
Software - 0.0%   
Trion World, Inc. 12% 10/10/19 pay-in-kind (d)(e)(h) 425 168 
Nonconvertible Bonds - 0.2%   
ENERGY - 0.2%   
Energy Equipment & Services - 0.2%   
Pacific Drilling V Ltd. 7.25% 12/1/17 (g) 9,250 4,163 
TOTAL CORPORATE BONDS   
(Cost $9,256)  4,331 
 Shares Value (000s) 
Other - 0.1%   
Energy - 0.1%   
Oil, Gas & Consumable Fuels - 0.1%   
Utica Shale Drilling Program (non-operating revenue interest) (d)(e)(f)   
(Cost $5,578) 5,578,436 4,295 
Money Market Funds - 7.0%   
Fidelity Cash Central Fund, 1.11% (i) 160,296,995 160,329 
Fidelity Securities Lending Cash Central Fund 1.11% (i)(j) 59,587,681 59,594 
TOTAL MONEY MARKET FUNDS   
(Cost $219,920)  219,923 
TOTAL INVESTMENT IN SECURITIES - 102.0%   
(Cost $2,661,216)  3,201,895 
NET OTHER ASSETS (LIABILITIES) - (2.0)%  (61,730) 
NET ASSETS - 100%  $3,140,165 

Values shown as $0 may reflect amounts less than $500.

Legend

 (a) Security or a portion of the security is on loan at period end.

 (b) Non-income producing

 (c) Investment is owned by an entity that is treated as a U.S. Corporation for tax purposes in which the Fund holds a percentage ownership.

 (d) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $27,997,000 or 0.9% of net assets.

 (e) Level 3 instrument

 (f) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (g) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $23,820,000 or 0.8% of net assets.

 (h) Coupon rates for floating and adjustable rate securities reflect the rates in effect at period end.

 (i) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (j) Investment made with cash collateral received from securities on loan.


Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost (000s) 
New Academy Holding Co. LLC unit 8/1/11 $6,956 
Peloton Interactive, Inc. Series E 3/31/17 $5,000 
Space Exploration Technologies Corp. Class A 4/8/16 - 4/6/17 $5,171 
Space Exploration Technologies Corp. Series H 8/4/17 $1,022 
Trion World, Inc. 8/22/08 - 3/20/13 $5,798 
Trion World, Inc. warrants 10/3/18 10/10/13 $0 
Trion World, Inc. 12% 10/10/19 pay-in-kind 10/10/13 - 4/10/17 $425 
Utica Shale Drilling Program (non-operating revenue interest) 10/5/16 - 11/4/16 $5,578 
WME Entertainment Parent, LLC Class A 8/16/16 $7,349 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
 (Amounts in thousands) 
Fidelity Cash Central Fund $687 
Fidelity Securities Lending Cash Central Fund 739 
Total $1,426 

Investment Valuation

The following is a summary of the inputs used, as of August 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.

 Valuation Inputs at Reporting Date: 
Description Total Level 1 Level 2 Level 3 
(Amounts in thousands)     
Investments in Securities:     
Equities:     
Consumer Discretionary $410,226 $394,814 $-- $15,412 
Consumer Staples 190,225 190,225 -- -- 
Energy 356,443 356,443 -- -- 
Financials 568,573 568,573 -- -- 
Health Care 372,077 348,575 23,502 -- 
Industrials 330,123 316,516 -- 13,607 
Information Technology 478,233 478,233 -- -- 
Materials 55,579 55,579 -- -- 
Real Estate 37,579 37,579 -- -- 
Telecommunication Services 38,088 38,088 -- -- 
Utilities 136,200 136,200 -- -- 
Corporate Bonds 4,331 -- 4,163 168 
Other 4,295 -- -- 4,295 
Money Market Funds 219,923 219,923 -- -- 
Total Investments in Securities: $3,201,895 $3,140,748 $27,665 $33,482 

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:

(Amounts in thousands)  
Investments in Securities:  
Beginning Balance $25,444 
Net Realized Gain (Loss) on Investment Securities -- 
Net Unrealized Gain (Loss) on Investment Securities (4,135) 
Cost of Purchases 12,205 
Proceeds of Sales (32) 
Amortization/Accretion -- 
Transfers into Level 3 -- 
Transfers out of Level 3 -- 
Ending Balance $33,482 
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at August 31, 2017 $(4,135) 

The information used in the above reconciliation represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Corporate bonds are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker supplied prices.

When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Quarterly Holdings Report
for

Fidelity® Series Growth Company Fund

August 31, 2017







XS7-QTLY-1017
1.968013.103





Investments August 31, 2017 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 97.9%   
 Shares Value 
CONSUMER DISCRETIONARY - 20.7%   
Auto Components - 0.0%   
Delphi Automotive PLC 12,900 1,243,560 
Automobiles - 1.7%   
Tesla, Inc. (a) 540,700 192,435,130 
Hotels, Restaurants & Leisure - 2.3%   
China Lodging Group Ltd. ADR (a) 107,900 12,247,729 
Chipotle Mexican Grill, Inc. (a) 19,800 6,270,858 
Dave & Buster's Entertainment, Inc. (a) 56,000 3,273,760 
Del Taco Restaurants, Inc. (a) 273,500 3,850,880 
Domino's Pizza, Inc. 41,698 7,599,877 
Dunkin' Brands Group, Inc. 66,700 3,439,052 
Hyatt Hotels Corp. Class A (a) 45,200 2,689,852 
Las Vegas Sands Corp. 228,500 14,214,985 
Marriott International, Inc. Class A 42,600 4,412,508 
McDonald's Corp. 406,900 65,091,793 
Papa John's International, Inc. 204,100 15,264,639 
Shake Shack, Inc. Class A (a)(b) 182,500 5,642,900 
Starbucks Corp. 1,111,300 60,965,918 
U.S. Foods Holding Corp. (a) 144,000 3,952,800 
Wingstop, Inc. 13,600 440,776 
Yum China Holdings, Inc. 554,400 19,603,584 
Yum! Brands, Inc. 310,600 23,860,292 
  252,822,203 
Household Durables - 0.0%   
Newell Brands, Inc. 62,598 3,022,231 
Sony Corp. sponsored ADR 36,400 1,442,532 
  4,464,763 
Internet & Direct Marketing Retail - 8.0%   
Amazon.com, Inc. (a) 510,099 500,203,079 
Blue Apron Holdings, Inc.:   
Class A (b) 429,600 2,251,104 
Class B 515,684 2,431,966 
Class B 128,920 641,764 
Ctrip.com International Ltd. ADR (a) 403,600 20,765,220 
Etsy, Inc. (a) 52,100 852,877 
Expedia, Inc. 197,600 29,315,936 
Groupon, Inc. (a) 2,700,700 11,991,108 
JD.com, Inc. sponsored ADR (a) 1,630,700 68,342,637 
Netflix, Inc. (a) 599,700 104,773,587 
Priceline Group, Inc. (a) 32,100 59,451,768 
The Honest Co., Inc. (a)(c)(d) 9,496 237,495 
TripAdvisor, Inc. (a)(b) 28,300 1,209,259 
Vipshop Holdings Ltd. ADR (a) 2,742,000 25,528,020 
Wayfair LLC Class A (a)(b) 916,301 65,066,534 
  893,062,354 
Leisure Products - 0.1%   
Callaway Golf Co. 559,100 7,793,854 
Media - 1.4%   
Comcast Corp. Class A 2,641,000 107,251,010 
Liberty Media Corp. Liberty Formula One Group Series C (a) 146,800 5,769,240 
Lions Gate Entertainment Corp.:   
Class A (b) 33,000 981,090 
Class B 24,900 698,943 
The Walt Disney Co. 451,800 45,722,160 
Turn, Inc. (Escrow) (c)(d) 205,882 148,235 
  160,570,678 
Multiline Retail - 0.2%   
Dollar General Corp. 50,800 3,686,048 
Dollar Tree, Inc. (a) 249,300 19,854,252 
Target Corp. 13,900 757,967 
  24,298,267 
Specialty Retail - 1.1%   
CarMax, Inc. (a) 50,148 3,367,438 
DavidsTea, Inc. (a)(b) 92,100 492,735 
Home Depot, Inc. 584,300 87,569,041 
L Brands, Inc. 39,400 1,427,068 
Lowe's Companies, Inc. 100,900 7,455,501 
RH (a) 408,698 19,122,979 
TJX Companies, Inc. 95,200 6,882,960 
  126,317,722 
Textiles, Apparel & Luxury Goods - 5.9%   
adidas AG 1,455,746 326,755,797 
Kering SA 138,800 52,098,425 
lululemon athletica, Inc. (a) 2,395,483 137,860,047 
LVMH Moet Hennessy - Louis Vuitton SA 51,855 13,620,737 
NIKE, Inc. Class B 782,400 41,318,544 
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) 2,640,600 69,791,058 
Tory Burch LLC (a)(c)(d)(e) 248,840 11,016,147 
Under Armour, Inc. Class C (non-vtg.) (a)(b) 126,059 1,903,491 
VF Corp. 116,500 7,324,355 
  661,688,601 
TOTAL CONSUMER DISCRETIONARY  2,324,697,132 
CONSUMER STAPLES - 5.1%   
Beverages - 2.1%   
Constellation Brands, Inc. Class A (sub. vtg.) 89,400 17,888,940 
Dr. Pepper Snapple Group, Inc. 48,400 4,406,820 
Monster Beverage Corp. (a) 2,021,000 112,812,220 
PepsiCo, Inc. 278,800 32,265,524 
The Coca-Cola Co. 1,584,200 72,160,310 
  239,533,814 
Food & Staples Retailing - 0.6%   
Costco Wholesale Corp. 261,700 41,018,858 
Drogasil SA 756,900 16,675,196 
Kroger Co. 69,200 1,513,404 
Walgreens Boots Alliance, Inc. 166,200 13,545,300 
  72,752,758 
Food Products - 0.4%   
Campbell Soup Co. 34,800 1,607,760 
General Mills, Inc. 44,900 2,391,374 
Kellogg Co. 30,100 1,970,346 
Lamb Weston Holdings, Inc. 152,200 6,922,056 
Mondelez International, Inc. 166,400 6,765,824 
The Hain Celestial Group, Inc. (a) 84,500 3,398,590 
The Hershey Co. 72,600 7,617,192 
The Kraft Heinz Co. 127,200 10,271,400 
  40,944,542 
Household Products - 0.3%   
Church & Dwight Co., Inc. 228,700 11,473,879 
Colgate-Palmolive Co. 119,600 8,568,144 
Kimberly-Clark Corp. 67,700 8,346,733 
Procter & Gamble Co. 25,900 2,389,793 
  30,778,549 
Personal Products - 0.8%   
Coty, Inc. Class A 2,245,200 37,225,416 
elf Beauty, Inc. 53,800 1,113,122 
Herbalife Ltd. (a) 438,800 30,281,588 
Unilever NV (Certificaten Van Aandelen) (Bearer) 309,800 18,443,707 
  87,063,833 
Tobacco - 0.9%   
Altria Group, Inc. 785,000 49,769,000 
British American Tobacco PLC sponsored ADR 215,100 13,362,012 
Philip Morris International, Inc. 325,700 38,084,101 
  101,215,113 
TOTAL CONSUMER STAPLES  572,288,609 
ENERGY - 1.2%   
Energy Equipment & Services - 0.2%   
Baker Hughes, a GE Co. Class A 373,000 12,644,700 
Halliburton Co. 103,200 4,021,704 
U.S. Silica Holdings, Inc. (b) 167,700 4,563,117 
  21,229,521 
Oil, Gas & Consumable Fuels - 1.0%   
Anadarko Petroleum Corp. 72,500 2,967,425 
Cabot Oil & Gas Corp. 347,300 8,873,515 
Concho Resources, Inc. (a) 119,300 13,238,721 
Continental Resources, Inc. (a) 133,400 4,524,928 
Diamondback Energy, Inc. (a) 85,200 7,735,308 
EOG Resources, Inc. 369,000 31,361,310 
Hess Corp. 26,200 1,019,180 
Noble Energy, Inc. 292,500 6,952,725 
PDC Energy, Inc. (a) 132,438 5,208,787 
Pioneer Natural Resources Co. 104,193 13,508,622 
Reliance Industries Ltd. 341,790 8,524,035 
Valero Energy Corp. 58,800 4,004,280 
  107,918,836 
TOTAL ENERGY  129,148,357 
FINANCIALS - 2.4%   
Banks - 1.0%   
Bank of America Corp. 309,500 7,393,955 
Citigroup, Inc. 144,200 9,809,926 
HDFC Bank Ltd. sponsored ADR 383,811 37,394,706 
JPMorgan Chase & Co. 481,500 43,763,535 
Signature Bank (a) 17,800 2,284,452 
Wells Fargo & Co. 218,000 11,133,260 
  111,779,834 
Capital Markets - 1.3%   
BlackRock, Inc. Class A 125,200 52,460,052 
BM&F BOVESPA SA 1,562,800 10,981,824 
Charles Schwab Corp. 1,930,500 77,026,950 
E*TRADE Financial Corp. (a) 88,200 3,617,082 
RPI International Holdings LP (a)(c)(d) 35,220 4,768,964 
T. Rowe Price Group, Inc. 16,600 1,400,376 
  150,255,248 
Consumer Finance - 0.1%   
American Express Co. 62,900 5,415,690 
Discover Financial Services 38,958 2,296,574 
  7,712,264 
TOTAL FINANCIALS  269,747,346 
HEALTH CARE - 18.4%   
Biotechnology - 14.3%   
AbbVie, Inc. 423,084 31,858,225 
ACADIA Pharmaceuticals, Inc. (a) 1,762,774 62,772,382 
Adverum Biotechnologies, Inc. (a) 135,400 372,350 
Agios Pharmaceuticals, Inc. (a)(b) 648,328 41,013,229 
Alexion Pharmaceuticals, Inc. (a) 412,700 58,772,607 
Alkermes PLC (a) 2,774,059 140,866,716 
Alnylam Pharmaceuticals, Inc. (a) 1,344,914 115,299,477 
Amgen, Inc. 378,800 67,339,276 
Array BioPharma, Inc. (a) 1,601,700 15,504,456 
aTyr Pharma, Inc. (a) 335,674 1,023,806 
BeiGene Ltd. ADR (a)(b) 560,783 38,649,164 
Biogen, Inc. (a) 96,200 30,453,072 
Bioverativ, Inc. 39,950 2,264,766 
bluebird bio, Inc. (a)(b) 792,081 98,891,313 
Calyxt, Inc. 430,700 6,546,640 
Celgene Corp. (a) 312,800 43,457,304 
Celldex Therapeutics, Inc. (a)(b) 573,743 1,411,408 
Cellectis SA sponsored ADR (a) 241,100 6,934,036 
Chimerix, Inc. (a) 749,031 3,565,388 
Coherus BioSciences, Inc. (a)(b) 762,292 11,015,119 
CytomX Therapeutics, Inc. (a) 210,038 3,629,457 
CytomX Therapeutics, Inc. (a)(f) 207,739 3,589,730 
Dicerna Pharmaceuticals, Inc. (a) 51,328 179,135 
Editas Medicine, Inc. (a) 232,062 4,898,829 
Exelixis, Inc. (a) 4,364,084 127,605,816 
Fate Therapeutics, Inc. (a) 112,873 426,660 
Five Prime Therapeutics, Inc. (a) 386,600 13,113,472 
Galapagos Genomics NV sponsored ADR (a) 266,100 24,611,589 
Genocea Biosciences, Inc. (a) 38,400 187,008 
Gilead Sciences, Inc. 533,100 44,625,801 
Global Blood Therapeutics, Inc. (a) 295,800 8,992,320 
Heron Therapeutics, Inc. (a) 539,151 8,895,992 
Intellia Therapeutics, Inc. (a) 243,938 5,130,016 
Intercept Pharmaceuticals, Inc. (a) 58,400 6,810,024 
Intrexon Corp. (a)(b) 134,000 2,643,820 
Ionis Pharmaceuticals, Inc. (a)(b) 2,233,882 119,780,753 
Ironwood Pharmaceuticals, Inc. Class A (a) 1,511,056 24,101,343 
Jounce Therapeutics, Inc. (b) 151,600 2,575,684 
Lexicon Pharmaceuticals, Inc. (a) 2,141,677 32,424,990 
Macrogenics, Inc. (a) 82,700 1,563,857 
Merrimack Pharmaceuticals, Inc. (b) 1,442,600 1,961,936 
Momenta Pharmaceuticals, Inc. (a) 1,640,395 27,640,656 
Opko Health, Inc. (a)(b) 22,274 142,554 
Protagonist Therapeutics, Inc. 144,700 2,362,951 
Prothena Corp. PLC (a) 651,377 40,020,603 
Regeneron Pharmaceuticals, Inc. (a) 283,300 140,771,770 
Regulus Therapeutics, Inc. (a) 1,663,832 1,663,832 
Rigel Pharmaceuticals, Inc. (a) 3,098,512 7,901,206 
Sage Therapeutics, Inc. (a) 544,534 44,787,922 
Seattle Genetics, Inc. (a) 591,117 31,051,376 
Seres Therapeutics, Inc. (a) 398,392 5,589,440 
Seres Therapeutics, Inc. (a)(f) 142,139 1,994,210 
Sienna Biopharmaceuticals, Inc. 216,500 5,416,830 
Sienna Biopharmaceuticals, Inc. 155,108 3,492,722 
Spark Therapeutics, Inc. (a) 134,400 11,065,152 
Syros Pharmaceuticals, Inc. (a) 237,860 4,654,920 
Syros Pharmaceuticals, Inc. (f) 301,001 5,890,590 
TESARO, Inc. (a) 119,200 15,393,488 
Ultragenyx Pharmaceutical, Inc. (a) 214,700 12,250,782 
Versartis, Inc. (a) 143,633 2,729,027 
Vertex Pharmaceuticals, Inc. (a) 82,600 13,260,604 
Xencor, Inc. (a) 247,700 5,355,274 
  1,599,194,875 
Health Care Equipment & Supplies - 1.6%   
Abbott Laboratories 175,621 8,946,134 
Align Technology, Inc. (a) 36,834 6,510,041 
Danaher Corp. 372,100 31,040,582 
DexCom, Inc. (a) 132,500 9,885,825 
Genmark Diagnostics, Inc. (a) 537,300 5,233,302 
Insulet Corp. (a) 613,720 35,632,583 
Intuitive Surgical, Inc. (a) 36,307 36,476,554 
Novocure Ltd. (a)(b) 492,200 10,090,100 
Novocure Ltd. (a)(f) 149,451 3,063,746 
Penumbra, Inc. (a) 401,892 34,562,712 
Presbia PLC (a) 443,695 1,326,648 
  182,768,227 
Health Care Providers & Services - 0.5%   
Humana, Inc. 11,700 3,014,154 
McKesson Corp. 27,800 4,150,818 
UnitedHealth Group, Inc. 223,600 44,474,040 
  51,639,012 
Health Care Technology - 0.3%   
athenahealth, Inc. (a) 232,800 32,808,504 
Castlight Health, Inc. Class B (a) 787,800 3,072,420 
Cerner Corp. (a) 35,200 2,385,856 
  38,266,780 
Life Sciences Tools & Services - 0.0%   
Illumina, Inc. (a) 14,962 3,059,131 
Pharmaceuticals - 1.7%   
Adimab LLC (a)(c)(d)(e) 762,787 26,133,083 
Akcea Therapeutics, Inc. 735,319 13,713,699 
Avexis, Inc. (a) 457,921 42,746,925 
Bristol-Myers Squibb Co. 485,800 29,381,184 
Castle Creek Pharmaceuticals, LLC Class A-2 unit (c)(d)(e)(g) 13,511 5,585,718 
Endocyte, Inc. (a)(b) 305,200 415,072 
Intra-Cellular Therapies, Inc. (a)(b) 986,698 18,204,578 
Jazz Pharmaceuticals PLC (a) 113,700 16,982,232 
Kolltan Pharmaceuticals, Inc. rights (d) 1,692,030 203,044 
Stemcentrx, Inc. rights 12/31/21 (d) 568,100 1,670,214 
The Medicines Company (a)(b) 704,623 25,852,618 
Theravance Biopharma, Inc. (a) 255,001 8,330,883 
  189,219,250 
TOTAL HEALTH CARE  2,064,147,275 
INDUSTRIALS - 5.9%   
Aerospace & Defense - 1.1%   
Lockheed Martin Corp. 138,500 42,296,515 
Northrop Grumman Corp. 18,400 5,008,664 
Space Exploration Technologies Corp. Class A (a)(c)(d) 137,569 18,571,815 
The Boeing Co. 157,500 37,746,450 
United Technologies Corp. 127,700 15,288,244 
  118,911,688 
Air Freight & Logistics - 0.3%   
FedEx Corp. 25,700 5,509,566 
United Parcel Service, Inc. Class B 286,100 32,718,396 
  38,227,962 
Airlines - 1.7%   
Allegiant Travel Co. 36,400 4,295,200 
Azul SA sponsored ADR (b) 153,500 3,839,035 
Delta Air Lines, Inc. 270,900 12,783,771 
InterGlobe Aviation Ltd. 170,729 3,279,994 
JetBlue Airways Corp. (a) 2,237,800 44,330,818 
Ryanair Holdings PLC sponsored ADR (a) 136,010 15,464,337 
Southwest Airlines Co. 721,400 37,613,796 
United Continental Holdings, Inc. (a) 461,000 28,563,560 
Wheels Up Partners Holdings LLC:   
Series B (a)(c)(d)(e) 1,843,115 5,750,519 
Series C(a)(c)(d)(e) 670,590 2,092,241 
Wizz Air Holdings PLC (a) 998,408 38,021,169 
  196,034,440 
Electrical Equipment - 0.3%   
AMETEK, Inc. 17,300 1,094,225 
Eaton Corp. PLC 125,500 9,005,880 
Emerson Electric Co. 111,200 6,565,248 
Fortive Corp. 188,000 12,214,360 
  28,879,713 
Industrial Conglomerates - 0.9%   
3M Co. 258,600 52,837,152 
Honeywell International, Inc. 315,800 43,665,666 
  96,502,818 
Machinery - 1.2%   
Aumann AG 65,600 5,096,383 
Caterpillar, Inc. 624,900 73,419,501 
Cummins, Inc. 74,800 11,921,624 
Deere & Co. 117,800 13,656,554 
Illinois Tool Works, Inc. 87,800 12,073,378 
Rational AG 1,300 844,208 
Wabtec Corp. (b) 58,600 4,135,402 
Xylem, Inc. 298,400 18,521,688 
  139,668,738 
Road & Rail - 0.3%   
Union Pacific Corp. 333,000 35,064,900 
Trading Companies & Distributors - 0.1%   
Univar, Inc. (a) 285,100 8,042,671 
TOTAL INDUSTRIALS  661,332,930 
INFORMATION TECHNOLOGY - 42.0%   
Communications Equipment - 0.3%   
Arista Networks, Inc. (a) 22,300 3,928,145 
Infinera Corp. (a)(b) 3,244,300 27,446,778 
Palo Alto Networks, Inc. (a) 23,100 3,065,139 
  34,440,062 
Electronic Equipment & Components - 0.2%   
Cognex Corp. 7,600 828,172 
IPG Photonics Corp. (a) 6,000 1,054,740 
TE Connectivity Ltd. 31,300 2,491,480 
Trimble, Inc. (a) 417,000 16,129,560 
  20,503,952 
Internet Software & Services - 11.8%   
2U, Inc. (a) 59,980 3,004,998 
Actua Corp. (a) 808,318 10,346,470 
Alibaba Group Holding Ltd. sponsored ADR (a) 359,100 61,671,834 
Alphabet, Inc.:   
Class A (a) 413,570 395,058,607 
Class C (a) 227,156 213,374,445 
Apptio, Inc. Class A 179,600 3,196,880 
Baidu.com, Inc. sponsored ADR (a) 32,400 7,388,820 
Cloudera, Inc. 113,172 2,085,760 
Criteo SA sponsored ADR (a)(b) 137,860 6,715,161 
eBay, Inc. (a) 154,600 5,585,698 
Facebook, Inc. Class A (a) 2,247,658 386,529,746 
GoDaddy, Inc. (a) 109,700 4,916,754 
NAVER Corp. 2,396 1,609,076 
NetEase, Inc. ADR 176,100 48,575,424 
New Relic, Inc. (a) 163,146 7,814,693 
Nutanix, Inc.:   
Class A (b) 884,700 19,463,400 
Class B (f) 274,751 6,044,522 
Okta, Inc. (b) 25,500 688,245 
Shopify, Inc. Class A (a) 1,018,449 112,549,319 
Tencent Holdings Ltd. 327,900 13,797,925 
Twitter, Inc. (a) 13,590 229,807 
Wix.com Ltd. (a) 272,907 17,766,246 
  1,328,413,830 
IT Services - 3.3%   
Black Knight Financial Services, Inc. Class A (a)(b) 25,000 1,065,000 
Cognizant Technology Solutions Corp. Class A 290,000 20,523,300 
IBM Corp. 70,100 10,026,403 
MasterCard, Inc. Class A 693,300 92,416,890 
PayPal Holdings, Inc. (a) 1,535,000 94,678,800 
Square, Inc. (a) 852,700 22,263,997 
Visa, Inc. Class A 1,250,400 129,441,408 
  370,415,798 
Semiconductors & Semiconductor Equipment - 10.3%   
Advanced Micro Devices, Inc. (a)(b) 2,609,100 33,918,300 
Applied Materials, Inc. 100,400 4,530,048 
ASML Holding NV 116,400 18,194,484 
Broadcom Ltd. 168,336 42,432,456 
Cavium, Inc. (a) 648,800 41,075,528 
Cirrus Logic, Inc. (a) 485,100 28,126,098 
Cree, Inc. (a) 307,066 7,470,916 
Cypress Semiconductor Corp. 181,400 2,483,366 
Inphi Corp. (a)(b) 104,400 3,997,476 
Intel Corp. 22,400 785,568 
KLA-Tencor Corp. 70,800 6,633,252 
M/A-COM Technology Solutions Holdings, Inc. (a)(b) 140,821 6,412,988 
Micron Technology, Inc. (a) 256,500 8,200,305 
NVIDIA Corp. 4,802,300 813,701,706 
Qorvo, Inc. (a) 66,000 4,832,520 
Silicon Laboratories, Inc. (a) 991,681 75,268,588 
Skyworks Solutions, Inc. 35,178 3,706,354 
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR 358,800 13,264,836 
Texas Instruments, Inc. 517,700 42,875,914 
  1,157,910,703 
Software - 10.2%   
Activision Blizzard, Inc. 2,439,300 159,920,508 
Adobe Systems, Inc. (a) 526,600 81,707,256 
Appirio, Inc. (Escrow) (c)(d) 100,642 24,806 
Atlassian Corp. PLC (a) 126,600 4,506,960 
Autodesk, Inc. (a) 250,500 28,672,230 
Electronic Arts, Inc. (a) 553,300 67,225,950 
HubSpot, Inc. (a) 513,200 37,643,220 
Intuit, Inc. 134,000 18,954,300 
Microsoft Corp. 3,188,892 238,433,455 
Oracle Corp. 292,500 14,721,525 
Paylocity Holding Corp. (a) 55,900 2,746,926 
Proofpoint, Inc. (a) 105,000 9,634,800 
Red Hat, Inc. (a) 1,078,500 115,938,750 
Salesforce.com, Inc. (a) 3,407,742 325,405,284 
Snap, Inc. Class A (a)(b) 1,160,497 16,838,811 
Zendesk, Inc. (a) 571,800 15,667,320 
  1,138,042,101 
Technology Hardware, Storage & Peripherals - 5.9%   
Apple, Inc. 3,854,165 632,083,060 
NetApp, Inc. 119,500 4,619,870 
Pure Storage, Inc. Class A (a)(b) 948,578 14,124,326 
Samsung Electronics Co. Ltd. 4,632 9,542,233 
Western Digital Corp. 26,620 2,349,747 
  662,719,236 
TOTAL INFORMATION TECHNOLOGY  4,712,445,682 
MATERIALS - 1.4%   
Chemicals - 1.4%   
CF Industries Holdings, Inc. 303,200 8,789,768 
E.I. du Pont de Nemours & Co. 390,800 32,799,844 
LyondellBasell Industries NV Class A 37,600 3,406,184 
Monsanto Co. 229,791 26,931,505 
Praxair, Inc. 52,200 6,866,388 
The Dow Chemical Co. 525,700 35,037,905 
The Mosaic Co. 77,800 1,554,444 
The Scotts Miracle-Gro Co. Class A 375,821 35,924,729 
  151,310,767 
Containers & Packaging - 0.0%   
Aptargroup, Inc. 15,100 1,262,511 
TOTAL MATERIALS  152,573,278 
REAL ESTATE - 0.2%   
Equity Real Estate Investment Trusts (REITs) - 0.2%   
American Tower Corp. 187,400 27,744,570 
Real Estate Management & Development - 0.0%   
Redfin Corp. 20,200 450,258 
TOTAL REAL ESTATE  28,194,828 
TELECOMMUNICATION SERVICES - 0.6%   
Diversified Telecommunication Services - 0.1%   
Verizon Communications, Inc. 281,400 13,498,758 
Wireless Telecommunication Services - 0.5%   
T-Mobile U.S., Inc. (a) 761,400 49,270,194 
TOTAL TELECOMMUNICATION SERVICES  62,768,952 
TOTAL COMMON STOCKS   
(Cost $6,352,357,100)  10,977,344,389 
Preferred Stocks - 1.7%   
Convertible Preferred Stocks - 1.6%   
CONSUMER DISCRETIONARY - 0.1%   
Hotels, Restaurants & Leisure - 0.0%   
MOD Super Fast Pizza Holdings LLC Series 3 Preferred (c)(d)(e) 16,248 1,938,386 
Household Durables - 0.0%   
Roku, Inc.:   
Series G, 8.00% (a)(c)(d) 661,380 1,236,781 
Series H (a)(c)(d) 228,870 427,987 
  1,664,768 
Internet & Direct Marketing Retail - 0.0%   
The Honest Co., Inc.:   
Series C (a)(c)(d) 22,157 669,806 
Series D (a)(c)(d) 19,064 610,239 
  1,280,045 
Leisure Products - 0.0%   
Peloton Interactive, Inc. Series E(c)(d) 194,028 4,202,996 
Textiles, Apparel & Luxury Goods - 0.1%   
Homology Medicines, Inc. Series B (c)(d) 958,333 1,380,000 
Rubius Therapeutics, Inc. Series B(c)(d) 333,731 3,444,104 
  4,824,104 
TOTAL CONSUMER DISCRETIONARY  13,910,299 
FINANCIALS - 0.1%   
Diversified Financial Services - 0.1%   
Neon Therapeutics, Inc. Series B (c)(d) 921,285 3,279,775 
UNITY Biotechnology, Inc. Series B (c)(d) 645,485 2,924,047 
  6,203,822 
Insurance - 0.0%   
Clover Health Series D (c)(d) 264,037 2,476,086 
TOTAL FINANCIALS  8,679,908 
HEALTH CARE - 0.5%   
Biotechnology - 0.4%   
10X Genomics, Inc. Series C (a)(c)(d) 715,467 3,204,004 
23andMe, Inc. Series F (c) 164,720 2,287,005 
Axcella Health, Inc. Series C (a)(c)(d) 111,581 1,124,736 
Immunocore Ltd. Series A (a)(c)(d) 18,504 6,274,275 
Intarcia Therapeutics, Inc. Series EE (c)(d) 116,544 6,992,640 
Moderna Therapeutics, Inc.:   
Series B(c)(d) 171,343 1,235,383 
Series C(c)(d) 111,846 806,410 
Series E (c)(d) 1,403,070 10,116,135 
Series F (c)(d) 1,538,270 11,090,927 
Translate Bio:   
Series B (a)(c)(d) 1,211,240 3,476,259 
Series C (c)(d) 566,997 1,627,281 
  48,235,055 
Health Care Providers & Services - 0.1%   
Mulberry Health, Inc. Series A8 (a)(c)(d) 783,663 4,981,746 
Health Care Technology - 0.0%   
Codiak Biosciences, Inc.:   
Series A (a)(c)(d) 163,914 540,916 
Series B (a)(c)(d) 532,720 1,757,976 
  2,298,892 
Pharmaceuticals - 0.0%   
OptiNose U.S., Inc. Series D(c)(d) 104,500 4,180,000 
TOTAL HEALTH CARE  59,695,693 
INDUSTRIALS - 0.2%   
Aerospace & Defense - 0.1%   
Space Exploration Technologies Corp. Series G (a)(c)(d) 53,937 7,281,495 
Commercial Services & Supplies - 0.0%   
Domo, Inc. Series D (a)(c)(d) 613,084 4,646,502 
Professional Services - 0.1%   
YourPeople, Inc. Series C (c)(d) 1,527,000 12,765,720 
TOTAL INDUSTRIALS  24,693,717 
INFORMATION TECHNOLOGY - 0.7%   
Internet Software & Services - 0.5%   
Jet.Com, Inc. Series B1 (Escrow) (a)(c)(d) 2,105,094 691,418 
Reddit, Inc. Series B (c)(d) 37,935 598,383 
Starry, Inc. Series B (c)(d) 2,961,147 1,601,981 
Uber Technologies, Inc.:   
Series D, 8.00% (a)(c)(d) 1,095,852 53,447,144 
Series E, 8.00% (a)(c)(d) 51,852 2,528,938 
  58,867,864 
IT Services - 0.1%   
AppNexus, Inc. Series E (a)(c)(d) 209,665 4,776,169 
Software - 0.1%   
Appirio, Inc. Series E (Escrow) (c)(d) 704,496 179,055 
Cloudflare, Inc. Series D 8.00% (a)(c)(d) 344,325 2,258,772 
Dataminr, Inc. Series D (a)(c)(d) 442,241 3,820,034 
Outset Medical, Inc. Series C(c)(d) 382,862 992,187 
Taboola.Com Ltd. Series E (a)(c)(d) 331,426 4,449,725 
  11,699,773 
TOTAL INFORMATION TECHNOLOGY  75,343,806 
TELECOMMUNICATION SERVICES - 0.0%   
Wireless Telecommunication Services - 0.0%   
Altiostar Networks, Inc. Series A1 (c)(d) 202,849 933,105 
TOTAL CONVERTIBLE PREFERRED STOCKS  183,256,528 
Nonconvertible Preferred Stocks - 0.1%   
FINANCIALS - 0.1%   
Banks - 0.1%   
Itau Unibanco Holding SA 498,400 6,388,627 
HEALTH CARE - 0.0%   
Biotechnology - 0.0%   
Yumanity Holdings LLC Class A (a)(c)(d) 130,754 1,461,830 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  7,850,457 
TOTAL PREFERRED STOCKS   
(Cost $150,253,357)  191,106,985 
Money Market Funds - 1.8%   
Fidelity Cash Central Fund, 1.11% (h) 54,352,877 54,363,748 
Fidelity Securities Lending Cash Central Fund 1.11% (h)(i) 144,652,589 144,667,054 
TOTAL MONEY MARKET FUNDS   
(Cost $199,024,400)  199,030,802 
TOTAL INVESTMENT IN SECURITIES - 101.4%   
(Cost $6,701,634,857)  11,367,482,176 
NET OTHER ASSETS (LIABILITIES) - (1.4)%  (151,741,515) 
NET ASSETS - 100%  $11,215,740,661 

Legend

 (a) Non-income producing

 (b) Security or a portion of the security is on loan at period end.

 (c) Restricted securities - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $259,047,381 or 2.3% of net assets.

 (d) Level 3 instrument

 (e) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (f) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $20,582,798 or 0.2% of net assets.

 (g) Investment represents common shares and preferred shares.

 (h) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (i) Investment made with cash collateral received from securities on loan.


Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost 
10X Genomics, Inc. Series C 2/23/16 - 4/3/17 $3,204,004 
23andMe, Inc. Series F 8/31/17 $2,287,005 
Adimab LLC 9/17/14 - 6/5/15 $11,583,995 
Altiostar Networks, Inc. Series A1 1/10/17 $933,105 
Appirio, Inc. (Escrow) 7/7/17 $23,217 
Appirio, Inc. Series E (Escrow) 11/24/16 $179,056 
AppNexus, Inc. Series E 8/1/14 $4,200,051 
Axcella Health, Inc. Series C 8/11/17 $1,124,736 
Castle Creek Pharmaceuticals, LLC Class A-2 unit 9/29/16 $4,458,630 
Cloudflare, Inc. Series D 8.00% 11/5/14 $2,109,163 
Clover Health Series D 6/7/17 $2,476,086 
Codiak Biosciences, Inc. Series A 11/12/15 $163,914 
Codiak Biosciences, Inc. Series B 11/12/15 $1,598,160 
Dataminr, Inc. Series D 2/18/15 - 3/6/15 $5,638,573 
Domo, Inc. Series D 1/24/14 $2,533,999 
Homology Medicines, Inc. Series B 7/28/17 $1,380,000 
Immunocore Ltd. Series A 7/27/15 $3,482,067 
Intarcia Therapeutics, Inc. Series EE 9/2/16 $6,992,640 
Jet.Com, Inc. Series B1 (Escrow) 9/19/16 $691,418 
MOD Super Fast Pizza Holdings LLC Series 3 Preferred 11/3/16 $2,225,976 
Moderna Therapeutics, Inc. Series B 0.00 4/13/17 $993,789 
Moderna Therapeutics, Inc. Series C 0.00 4/13/17 $649,825 
Moderna Therapeutics, Inc. Series E 12/18/14 $10,570,104 
Moderna Therapeutics, Inc. Series F 8/10/16 $11,588,640 
Mulberry Health, Inc. Series A8 1/20/16 $5,293,448 
Neon Therapeutics, Inc. Series B 12/28/16 $2,588,811 
OptiNose U.S., Inc. Series D 0.00 3/24/17 $3,432,825 
Outset Medical, Inc. Series C 0.00 4/19/17 $992,187 
Peloton Interactive, Inc. Series E 0.00 3/31/17 $4,202,996 
Reddit, Inc. Series B 7/26/17 $538,544 
Roku, Inc. Series G, 8.00% 10/1/14 $859,496 
Roku, Inc. Series H 11/9/15 $349,919 
RPI International Holdings LP 5/21/15 - 3/23/16 $4,390,645 
Rubius Therapeutics, Inc. Series B 0.00 6/7/17 $2,800,003 
Space Exploration Technologies Corp. Class A 10/16/15 - 4/6/17 $12,876,729 
Space Exploration Technologies Corp. Series G 1/20/15 $4,177,960 
Starry, Inc. Series B 12/1/16 $1,601,981 
Taboola.Com Ltd. Series E 12/22/14 $3,455,249 
The Honest Co., Inc. 8/21/14 $256,936 
The Honest Co., Inc. Series C 8/21/14 $599,509 
The Honest Co., Inc. Series D 8/3/15 $872,273 
Tory Burch LLC 5/14/15 $17,704,966 
Translate Bio Series B 7/17/15 $1,308,139 
Translate Bio Series C 12/22/16 $1,122,654 
Turn, Inc. (Escrow) 4/11/17 $148,235 
Uber Technologies, Inc. Series D, 8.00% 6/6/14 $17,000,007 
Uber Technologies, Inc. Series E, 8.00% 12/5/14 $1,727,583 
UNITY Biotechnology, Inc. Series B 10/14/16 $2,652,943 
Wheels Up Partners Holdings LLC Series B 9/18/15 $5,235,000 
Wheels Up Partners Holdings LLC Series C 6/22/17 $2,092,241 
YourPeople, Inc. Series C 5/1/15 $22,753,949 
Yumanity Holdings LLC Class A 2/8/16 $883,727 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
Fidelity Cash Central Fund $184,341 
Fidelity Securities Lending Cash Central Fund 1,219,288 
Total $1,403,629 

Investment Valuation

The following is a summary of the inputs used, as of August 31, 2017, involving the Fund's assets and liabilities carried at fair value. The inputs or methodology used for valuing securities may not be an indication of the risk associated with investing in those securities. Additional information on valuation inputs, and their aggregation into the levels used below, is provided later in this section.

 Valuation Inputs at Reporting Date: 
Description Total Level 1 Level 2 Level 3 
Investments in Securities:     
Equities:     
Consumer Discretionary $2,338,607,431 $2,296,600,788 $16,694,467 $25,312,176 
Consumer Staples 572,288,609 553,844,902 18,443,707 -- 
Energy 129,148,357 129,148,357 -- -- 
Financials 284,815,881 271,367,009 -- 13,448,872 
Health Care 2,125,304,798 2,027,062,494 3,492,722 94,749,582 
Industrials 686,026,647 634,918,355 -- 51,108,292 
Information Technology 4,787,789,488 4,696,537,191 15,883,685 75,368,612 
Materials 152,573,278 152,573,278 -- -- 
Real Estate 28,194,828 28,194,828 -- -- 
Telecommunication Services 63,702,057 62,768,952 -- 933,105 
Money Market Funds 199,030,802 199,030,802 -- -- 
Total Investments in Securities: $11,367,482,176 $11,052,046,956 $54,514,581 $260,920,639 

The following is a summary of transfers between Level 1 and Level 2 for the period ended August 31, 2017. Transfers are assumed to have occurred at the beginning of the period, and are primarily attributable to the valuation techniques used for foreign equity securities, as discussed at the end of this section:

Transfers Total 
Level 1 to Level 2 $0 
Level 2 to Level 1 $234,830,511 

The following is a reconciliation of Investments in Securities for which Level 3 inputs were used in determining value:

Investments in Securities:  
Beginning Balance $235,622,156 
Net Realized Gain (Loss) on Investment Securities (2,738,597) 
Net Unrealized Gain (Loss) on Investment Securities 16,814,878 
Cost of Purchases 34,346,579 
Proceeds of Sales (23,124,377) 
Amortization/Accretion -- 
Transfers into Level 3 -- 
Transfers out of Level 3 -- 
Ending Balance $260,920,639 
The change in unrealized gain (loss) for the period attributable to Level 3 securities held at August 31, 2017 $16,197,240 

The information used in the above reconciliations represents fiscal year to date activity for any Investments in Securities identified as using Level 3 inputs at either the beginning or the end of the current fiscal period. Transfers in or out of Level 3 represent the beginning value of any Security or Instrument where a change in the pricing level occurred from the beginning to the end of the period. The cost of purchases and the proceeds of sales may include securities received or delivered through corporate actions or exchanges.

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. Utilizing these techniques may result in transfers between Level 1 and Level 2. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy. Equity securities, including restricted securities, for which observable inputs are not available, are valued using alternate valuation approaches, including the market approach and the income approach and are categorized as Level 3 in the hierarchy. The market approach generally consists of using comparable market transactions while the income approach generally consists of using the net present value of estimated future cash flows, adjusted as appropriate for liquidity, credit, market and/or other risk factors.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

The following provides information on Level 3 securities held by the fund that were valued at period end based on unobservable inputs. These amounts exclude valuations provided by a broker.

Asset Type Fair Value Valuation Technique (s) Unobservable Input Amount or Range / Weighted Average Impact to Valuation from an Increase in Input(a) 
Equities $260,920,639 Recovery value Recovery value 0.2% - 0.7% / 0.4% Increase 
  Market approach Transaction price $0.54 - $135.00 / $60.61 Increase 
  Market comparable Enterprise value/EBITDA multiple (EV/EBITDA) 6.9 Increase 
   Enterprise value/Sales multiple (EV/S) 0.7 - 14.3 / 5.1 Increase 
   Transaction price $1.44 - $330.00 / $52.97 Increase 
   Discount rate 8.0% - 69.0% / 30.9% Decrease 
   Discount for lack of marketability 10.0% - 20.0% / 16.0% Decrease 
   Liquidity preference $6.75 - $65.88 / $31.04 Increase 
   Premium rate 15.0% - 144.0% / 49.3% Increase 
   Proxy premium 10.0% - 76.0% / 29.3% Increase 
  Discount cash flow Discount rate 8.0% - 12.2% / 10.8% Decrease 
   Discount for lack of marketability 10.0% Decrease 
   Probability rate 6.3% - 69.0% / 6.8% Increase 

 (a) Represents the expected directional change in the fair value of the Level 3 investments that would result from an increase in the corresponding input. A decrease to the unobservable input would have the opposite effect. Significant changes in these inputs could result in significantly higher or lower fair value measurements.


For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.


Item 2.

Controls and Procedures


(a)(i)  The President and Treasurer and the Chief Financial Officer have concluded that the Fidelity Mt. Vernon Street Trusts (the Trust) disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act) provide reasonable assurances that material information relating to the Trust is made known to them by the appropriate persons, based on their evaluation of these controls and procedures as of a date within 90 days of the filing date of this report.


(a)(ii)  There was no change in the Trusts internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act) that occurred during the Trusts last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Trusts internal control over financial reporting.


Item 3.

Exhibits


Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.




SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Fidelity Mt. Vernon Street Trust



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

October 27, 2017


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



By:

/s/Stacie M. Smith


Stacie M. Smith


President and Treasurer



Date:

October 27, 2017



By:

/s/Howard J. Galligan III


Howard J. Galligan III


Chief Financial Officer



Date:

October 27, 2017